SRMC Changes Emergency Department

By Tiffany Thompson, The Stanly News & Press, Albemarle, N.C.

Aug. 6–Stanly Regional Medical Center (SRMC) continues to move towards better healthcare as the facility begins to make changes to the emergency department (ED).

Brian Freeman, vice president of Ambulatory Services, decided the ED needed to move in a different direction following an evaluation of the department and its physician group.

The result was the partnering with ApolloMD, which is a physician owned and operated national group practice with nearly 30 years of experience in Atlanta, Ga.

“We expect great things from ApolloMD and we’re excited about the things to come,” Freeman said.

The partnership officially began on July 1 and is currently in its beginning stages. Freeman expects for the new physician group to be fully staffed by next June.

“It may not take that long. We may get lucky and have several physicians come on board with experience, but we may have to wait for new graduates in May that want to complete a fellowship with us,” Freeman said.

ApolloMD provides physicians for hospitals by recruiting board certified or board eligible physicians in emergency medicine.

While ApolloMD also provides anesthesia services, they will only be providing emergency medical services for SRMC.

The physicians are compensated based on the patients they treat and the procedures they perform. Also, the level of patient satisfaction may play a part in the compensation.

The physicians coming on board will not be employees of the hospital, but another round of changes to the department will include new employees of the hospital.

These employees, or medical assistants, will be a staffing change to the department. They will be responsible for registration and triage, but their work does not stop there.

They will also improve customer relations with patients and family members by communicating to family about patient updates while enforcing the department’s 2-visitor policy.

“When I came on board, I realized the department lacked customer satisfaction,” said Lori Shue, RN, BSN, CEN director of Emergency Services.

Shue said many of the changes to the staffing was the result of complaints the department has received from patients and their family members.

Among these complaints was the wait time between registration and being admitted to a room.

That is also changing as the medical assistants will be able to complete bedside registration and triage, though this service will only be available daily until 11 p.m.

Six medical assistants will rotate through shifts, which is phase one of the staffing changes.

Phase two will include increasing nursing competency and education and phase three will incorporate CNAs.

Additional changes include installing televisions and courtesy phones in the patient rooms as well as including a more advanced eye care capacity and detailed diagnostic testing at the bedside.

As a way to accomodate these changes, plans are under way to complete renovations for the department’s entrance and lobby.

“We are constantly taking a look at our processes and ways to cut down patient turnaround time while increasing our quality and proficiency,” said Freeman.

Contact Tiffany Thompson at (704) 982-2121 ext. 24 or [email protected].

—–

To see more of The Stanly News & Press or to subscribe to the newspaper, go to http://thesnaponline.com.

Copyright (c) 2008, The Stanly News & Press, Albemarle, N.C.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Living Nutrition Intestinal Gymnastics Can Get Things Moving

By Lydia Gehring

The topic was unlikely for a small group of professional women. We were enjoying a much-needed lunch break during a dietetic conference. The youngest in the group was a new mother. Her toddler was constipated and we were brainstorming.

The small boy had not pooped in four days and the mom was frantic. She had her hand on top of her cell phone and was eagerly awaiting a call from the daycare worker.

The little guy was teething and beginning to walk. Her mother-in- law was visiting from Seattle and they had a new puppy. She had been working extra hours at her job and her husband was involved with legal battles at his place of employment.

Each of these situations could cause stress in the family. The deduction over lunch was that the tike was reacting from the tension around him: physically, mentally and emotionally.

Constipation is not uncommon during times of duress. Stress can cause the body to become anal retentive.

Adequate fluids are vital. Whole grains and fiber from fruits and vegetables aid in elimination. Bulking agents, like Metamucil, will suffice but without adequate water, they can become concrete-like in the bowels.

I recommended the frustrated mom not resort to suppositories, lactulose, or other bowel stimulants at this point. I would only try these as a final resort. The last thing the family needed was a baby with the runs.

Pre- and pro-biotics may be the way to go at this point. Yogurt with active cultures (Dannon) and other over-the-counter biotics can be beneficial for the little boy’s intestines.

Another dietitian suggested trying to get the toddler to eat pineapple, applesauce and, of course, prunes or other dried fruit, like raisins. Pineapple has enough fiber to be helpful and some digestive enzymes. Applesauce has soluble and insoluble fiber. The mom was warned about prune juice. Diluting it 1 to 10 with water is a good way to start things moving.

The topic of corn syrup came up. Otherwise known as white karo syrup, corn syrup is a home remedy from Grandma’s day. Like many other tried and true homemade solutions, success may vary. In a pediatric population dietary changes, corn syrup, or both can resolve constipation in most children.

We talked about exercise. His little insides can benefit from physical movement. Crawling and first steps can stimulate those tiny intestines. Even laughing or giggling is like a workout for the gut. It may sound like torture to some people but a good belly tickle can help a person poop. When the new mom laughed I asked her to place her hand on her abdomen and continue laughing; she felt the internal gut gymnastics. Rubbing and massaging the belly should not be reserved only for the new puppy; physical belly rubs can also get things moving.

The new mom jumped when her phone rang. The caller informed her that her little boy had recently filled his diaper. She kept one hand on her stomach as she laughed with relief.

Upon hanging up she looked at her lunch companions, thanked us and excused herself to the restroom.

Bobbie Randall is a registered, licensed dietitian in Wooster. Contact her at [email protected].

(c) 2008 Daily Record, The Wooster, OH. Provided by ProQuest Information and Learning. All rights Reserved.

Glen Burnie West: Cookware, Clothing Sale Benefits BWMC Fund

By Kathleen Shatt for The Maryland Gazette

The Baltimore Washington Medical Center Auxiliary will sponsor an active wear and cookware sale from 7 a.m. to 4 p.m. Monday and Tuesday in the Dr. Constantine Padussis Conference Center, on the third floor of the hospital, 301 Hospital Drive.

Cookware sale items will include merchandise from Nordicware, T- Fal, Oxo, Wilton and Progressive. Boxed sets and open stock items will be available in addition to toasters, deep fryers, irons, bakeware and small appliances.

Active wear from Baby Phat, Rocawear, Sean Jean, Apple Bottom and others will also be sold.

Purchases may be paid for with cash or a major credit card. In addition, hospital employees with employee identification can arrange for payroll deductions.

Auxiliary member Pat Backhaus is the chairman of the sale.

Proceeds will benefit the medical center’s building fund.

For more information, call the auxiliary at 410-787-4504.

Summer bash

The Glen Burnie Park Swim Club will host a summer bash from 8 p.m. to midnight Aug. 16 at the community pool, 500 Everett Road.

Admission is $25. Only adults ages 21 and older will be allowed to attend. Tickets are available through Sunday to both members and nonmembers of the pool.

Beef, turkey, shrimp, salads and desserts will be provided along with music. Participants should take their own beverages. The event also will include raffles.

For more information, call 410-768-2494, send e-mail to [email protected] or visit www.gbpswim.com.

VFW Post 160

The Veterans of Foreign Wars Post 160 and its Ladies Auxiliary will meet at 8 p.m. Monday at the post hall, 2597 Dorsey Road.

New members are welcome. Membership in the post is open to veterans who served overseas in certain zones as active-duty members of any branch of military service during wars and specified conflicts.

For more information, call the post at 410-766-9802.

Bingo at Slade

The Monsignor Slade Catholic School sponsors bingo games at 8 p.m. Fridays in the school cafeteria, 120 Dorsey Road.

Early bird games will begin at 7:30 p.m.

Cash prizes worth more than $3,000 are available.

Refreshments will be sold through intermission.

For more information, call the school at 410-766-7130.

Pascal Senior Center

The Mass Transit Administration will issue reduced fare photo identification cards to senior citizens from 10 to 11:30 a.m. Friday at the Pascal Senior Center, 125 Dorsey Road. Seniors can use the cards to pay reduced fares on the light rail, metro and buses.

The discount cards are issued only to seniors ages 65 and older. Participants must provide proof of age.

Also at the senior center:

The movie “August Rush” will be shown at 12:30 p.m. Friday. Admission is free.

The center will host a pizza and movie night on Tuesday. Participants are requested to sign up in advance for the pizza, which will be served at 4:30 p.m. The cost is $3 in advance or $4 at the door. The movie “27 Dresses” starring Katherine Heigl and James Marsden will be shown at 5:30 p.m.

The center will host a bus trip to for its members Toby’s Dinner Theatre in Baltimore on Aug. 21 to view “West Side Story.” The bus will leave Sawmill Creek Park at 9:45 a.m. and return at 4 p.m. The cost is $60, which includes transportation, the show and buffet.

The center will host another member’s only bus trip to Dorchester County on Sept. 10 to the Suicide Bridge restaurant for a Choptank River boat ride and crab feast. The cost is $63, which includes bus transportation, taxes and gratuities. The seniors will depart at 9 a.m. from Sawmill Creek Park and return at 5 p.m.

Center members will travel to the Allegheny Mountains for a railroad adventure Oct. 1 through 3. The trip includes a scenic train ride from Pittsburgh to Altoona through the Allegheny mountains aboard Amtrak’s Pennsylvanian. Other stops include Phipps Conservatory and Gardens, Station Square, Three River Railroaders Museum, Johnstown Flood Museum, Inclined Plane, Basilica of St. Michael the Archangel and the Mount Assisi Sunken Gardens. The cost is $429 per person for double occupancy, $418 per person for triple occupancy and $529 per person for single occupancy.

For more information, call the center at 410-222-6680.

Bus trips

Glen Burnie Chapter 606 of the AARP will host several bus trips this summer and fall.

A trip to the Suicide Bridge restaurant in Dorchester County on Aug. 15 will cost $72. The trip includes bus transportation, a boat ride, buffet luncheon and crab feast.

The bus will leave the Glen Burnie parking garage at 10:30 a.m. and return at 6:30 p.m.

A tour of the Hudson Valley in upstate New York Sept. 3 through 5 will cost $419 per person for double occupancy. The trip includes a tour of the Military Academy at West Point and the Culinary Institute of America.

The chapter will travel Nov. 14 to the American Music Theater to see the holiday Christmas show and eat lunch at Shady Maple restaurant. The trip costs $72. The bus will leave the Glen Burnie parking garage at 9:30 a.m.

A trip to the holiday craft fair in Harrisburg, Pa., on Dec. 5 will cost $36. The bus will leave the Glen Burnie parking garage at 8 a.m. and will stop for dinner at a Cracker Barrel restaurant on the way home.

For more information, call trip coordinator Neoma Dearing at 410- 766-4667.

CASOS club

The Happy Community Advocates for Senior Opportunities and Services will meet at 10 a.m. Saturday and Aug. 23 in the former county utilities building, 7409 Baltimore Annapolis Blvd. Participants should park behind the building and use the rear entrance.

The group will begin with a social hour at 10 a.m. The business meeting will begin at 11 a.m.

All seniors ages 55 and older are welcome.

For more information, call Betty Betz at 410-969-3655.

North Glen bingo

The North Glen Improvement Association hosts bingo games Mondays in the community hall, 303 Wellham Ave.

The doors open for seating at 6 p.m. Bingo games begin at 7 p.m.

For details, contact Nancy Mason, president of the association, at 410-761-4894 or [email protected].

Hall rental

The Ferndale Volunteer Fire Company hall, 4 S. Broadview Blvd., is available for rent for all occasions.

Catering is also available.

For details, call 443-710-5441.

Another bus trip

The Glen Burnie Lions Club will host a bus trip to the Suicide Bridge restaurant and the Midway slots casino on Aug. 16.

The bus will depart at 11 a.m. from the Lutheran Church of Our Redeemer, 7606 Quarterfield Road. The group will arrive at 12:30 p.m. for a boat cruise on the Choptank River and crab feast of steamed crabs, corn on the cob, clam strips, crab soup, coleslaw, desserts, nonalcoholic drinks and beer aboard a sternwheeler boat.

Then, the group will depart at 3:30 p.m. for a trip to the Herrington Casino for gambling until 8:30 p.m. The group will return to Glen Burnie at 10:30 p.m.

The cost of the trip is $70.

For more information, call Paula Bohle at 410-969-7951 or John Hain at 410-242-3310 or 410-242-4267, or Catherine Lewis at 410-768- 0408.

Pizza Hut fundraiser

Glen Burnie United Methodist Church will host a fundraiser from 5 to 9 p.m. at the East Park Pizza Hut in the I-97 shopping center, 7938 Crain Highway S.

Patrons must present a fundraising flier to the cashier when they pay their bill for either dining room or carry-out orders. A portion of the meal will be donated to the church to support an upcoming mission trip to Louisiana.

For more information, call the church at 410-761-4381.

BAY days

Fellowship Baptist Church, 1015 Sundown Road, will sponsor its fifth annual Baltimore Area Youth program from 5 to 9 p.m. Aug. 14 and 15 and all day Aug. 16, beginning at 9 a.m.

Teenagers ages 13 to 18 in grades 7 to 12 are welcome to attend.

Evangelist Ben Schettler from Tampa, Fla., will be the guest speaker. He will talk about issues confronting teenagers today, including how to turn negative influences into positive ones.

The cost is $55 and includes dinner each evening and a trip to the Six Flags amusement park in Largo on Aug. 16. Planned activities include skits and games.

The deadline for registration is Friday.

For more information, call the Rev. Michael Hubers at 410-760- 7755 or visit www.fellowshipofferndale.org.

Clubs and organizations in the 21061 ZIP code area can call Maryland Gazette correspondent Kathleen Shatt at 410-766-8547 for publication of their news. They can also fax information to her at 410-766-1520 or send e-mail to [email protected]. {Corrections:} {Status:}

(c) 2008 Maryland Gazette. Provided by ProQuest Information and Learning. All rights Reserved.

Family Doctor Returns to Roots

By Arline A Fleming

Aaron Way, 32, who grew up in Hope Valley and was a teen volunteer at Westerly Hospital, finds you can go home again.

SOUTH KINGSTOWN — Dr. Jeffery Bandola often inquires — along with the well-being of his patients — about their gardens and their children.

But he never expected he’d be inviting one of those children to join his practice.

“I would always inquire, and I followed his career,” Bandola recalled of his conversations with the parents of Aaron Way, now Dr. Aaron Way, who is about to be listed among the physicians found at the South County Hospital Medical Office Building.

Monday was his first official day on the job, with a list of patients to meet, and a local reputation to uphold. Given that he’s spent three-fourths of his 32 years in South County, a patient could very well turn out to be a former neighbor, coach, or fellow scout.

Or, since Way has chosen primary care as his field of expertise, the day could also offer a cranky baby or the baby’s grandmother.

“That’s the plan,” Way said. “As a family doctor, we do infants on up.

“It just seems natural to settle into a field that requires a broad range of knowledge.”

His parents, Donald and Crystal Way, actually brought their son, as a youngster, to Bandola for a medical concern that neither doctor can now recall. But Bandola does clearly remember hearing that their son, who had grown into a young medical student, was interested in returning to the area for work.

Bandola, who has more than 2,000 patients, was about to become a patient himself a few months back, and so the idea of nurturing another doctor as a backup, should health issues linger, seemed timely and fortuitous. He knew of doctors who spent a year recruiting help.

“It just sort of fell in my lap,” said Bandola smiling, looking as if he has chosen the winning ticket among busy doctors competing for help.

According to Dr. Nitin Damle, a co-founder of South County Internal Medicine, in Wakefield, which has seven doctors, hiring additional primary care doctors is an ongoing issue.

“We’re always looking,” he said.

Damle, a past president of the medical staff at South County Hospital and governor of the Rhode Island Chapter of the American College of Physicians, said “the climate out there for primary care is not good. The percentage of medical students going into primary care is diminishing and has been for a number of years.”

Given the large amount of debt students accumulate by the time they finish medical school is one reason that medical students might choose to go into “higher-paying specialties, he said. Reimbursement is at a higher level than for primary care or for family practice.”

DR. AARON WAY stood in line waiting to graduate from Chariho High School just 14 years ago. He made his way to the University of Rhode Island, earning his bachelor’s and master’s degrees in microbiology.

Before joining Bandola’s practice, the former Hope Valley resident went to medical school at the Lake Erie College of Osteopathic Medicine in Erie, Pa., and completed his residency at the University of Massachusetts in the Fitchburg Family Medicine Residency program.

Monday was Day l for Way, who has chosen primary care as his career. His first patient had telephoned last week hoping for an opening, only to discover the addition of a new doctor.

“Good luck,” said office manager Pat Gallagher, as the young doctor approached the room where he would meet his patient, Nancy Richards, of Narragansett.

He checked her file, knocked on the door, and then introduced himself as he shook her hand.

“I was looking at your resume,” Richards told him, “and I’m impressed.”

That biography which hangs in the waiting room reads in part:

“As an osteopathic family physician, Dr. Way diagnoses and treats diseases, physiological disorders and injuries of adults, children and seniors. He provides comprehensive primary care with emphasis on preventative medicine …”

Way said he also is enjoying teaching and has commitments at UMass medical school to complete during the next two years. But he said he wanted to reaffirm his South County connections and familiarize himself with Bandola’s practice and patients. He’ll commute once a week from his home in Gardner, Mass., north of Worcester. His parents still live in Hope Valley, and he has a sister, Elise, in Westerly, and a brother, Jason, in Rockville, Mass.

WAY, WHO WAS an Eagle Scout, he said, is returning to the hospital-type work he began as a teenager at Westerly Hospital.

“I’ve always been interested in medicine and the sciences. I volunteered at Westerly Hospital doing candy-striper type stuff. That’s probably where it all started.”

Actually, it could have started at Hope Valley Elementary School, where he was also a student, not all that far from where he and his wife, Lalanya, hope to build a permanent home. They have a 2-year- old daughter, Amanda.

“I love the area,” said Way. “There are plenty of opportunities for outdoor activities.”

Way says he enjoys treating patients of all ages, recalling a Pennsylvania practice where he was assigned to do a rotation, working with the one doctor who “was the only one in a 40-mile radius. It was amazing how one person can affect so many people.”

It was a rural area, he said, and patients would come in very sick, not having seen a doctor in a long time.

Way suspects that one of the reasons why he decided upon primary care is that during his medical rotations he discovered an interest in all aspects of medical care.

“I like everything,” he said.

PRIMARY CARE, said Bandola, “is dying, and it really shouldn’t.” He suspects other aspects of medicine are more lucrative, and so attract larger numbers of medical school graduates.

“I’m extremely delighted,” Bandola said, to have Way join the office.

“It feels like a gift to me.”

Hopkinton

Primary care physician Aaron Way meets with his first patient of the day, Nancy Richards, of Narragansett. Way graduated from Chariho High School. The Providence Journal / Mary Murphy

Way talks with office manager Pat Gallagher in the office at the South County Hospital Medical Office Building, in South Kingstown. Way will commute once a week from his home in Gardner, Mass.

“As a family doctor, [I] do infants on up. It just seems natural to settle into a field that requires a broad range of knowledge,” says Dr. Aaron Way. The Providence Journal / Mary Murphy [email protected] / (401) 277-7404

Originally published by Arline A Fleming, Journal Staff Writer.

(c) 2008 Providence Journal. Provided by ProQuest Information and Learning. All rights Reserved.

Southeast Asian Community News

Meditation sessions: Dhamagosnaram Buddhist Temple, 2870 Plainfield Pike, Cranston, holds meditation sessions on Wednesday from 7 to 8 p.m.

Space is limited, so anyone interested in attending must call (401) 942-2084.

Health fair: The Southeast Asian Health Coalition (SEAHC) and the Socio-Economic Development Center for Southeast Asians (SEDC), in collaboration with Neighborhood Health Plan of R.I. will hold a “Cover the Uninsured” enrollment event and community health fair on Saturday from 10 a.m. to 2 p.m. at SEDC, 270 Elmwood Ave.

Included will be free health screenings provided by The Family Van, information booths, giveaways for students, music and children’s activities.

Native speakers will be available to answer questions.

The event is free and open to the public.

For more information, call (401) 277-3637 or email [email protected].

Graduation: The Socio-Economic Development Center for Southeast Asians, 270 Elmwood Ave., will hold a graduation ceremony for its Summer Academy on Friday at 4 p.m. at Esek Hopkins Middle School, 480 Charles St.

Participants in the academy attended classes in English, math and physical education as well as educational workshops on pregnancy prevention and the dangers of alcohol, substance abuse and gang involvement.

The ceremony will be followed by an ethnic dinner.

For information, call Nimith Mak, (401) 274-8811.

Appointed: PrYSM (Providence Youth Student Movement), 807 Broad St., has announced the following new board members:

Michael Van Leesten, president, The Van Leesten Group; Sean Phou, insurance agent, Nationwide; Sonn Sam, principal, The MET School, Peace Street Campus; Molly Soum, transition specialist, The Genesis Center; Sarath Suong, men’s health coordinator, Boston GLASS and Robert Lee, associate professor of American civilization, Brown University.

For information, visit www.prysm.us.

Grant: seaQuel (Queers United for Empowerment and Leadership), a program of PrYSM, has received a $100,000 three-year grant from the Queer Youth Fund-Liberty Hill Foundation to create a local non- school-based gay-straight alliance to reduce homophobia within the Southeast Asian community and to work for more inclusiveness of Southeast Asians and minorities in the Rhode Island gay-lesbian community.

For more information, contact Mimi at [email protected].

Columns that run in the Metro Edition are meant to reflect the diversity and cohesiveness of the various groups in the Providence area. We are interested in the news from your community — meetings, celebrations, events. If you have items that you would like us to include, please contact Stephanie McKenna at (401) 277-7312 or by e- mail at s/ [email protected] or by writing to her at The Providence Journal, 75 Fountain St., Providence, RI 02902.

(c) 2008 Providence Journal. Provided by ProQuest Information and Learning. All rights Reserved.

Middletown, Ohio, Hospital Offers One-Stop Shop for Women’s Health Care

By Tiffany Y. Latta, Middletown Journal, Ohio

Aug. 5–MIDDLETOWN — Health care providers at Atrium Medical Center have come up with a way to encourage women to be proactive about their health.

The Wilbur & Mary Jean Cohen Women’s Center is now a one-stop shop where patients can get mammograms, gynecology exams, bone density tests, health screenings, family planning and services for new moms.

Janet Majors, director of Women’s Services, said the center is an assist to women with busy lives.

“A lot of women work and have kids and family and don’t schedule annual exams because they’re too busy,” Majors said. “Here, they can have all their tests done in one day.” The Women’s Center was established at Middletown Regional Hospital in 2006 and expanded in 2008 when the hospital moved to Atrium Medical Center.

The 10,000-square-foot facility boasts of state-of-the art breast diagnostics and digital mammography that can better detect cancer, especially in younger women with dense breasts.

The center is a godsend for Carolyn Tucker, 58, of Madison Twp.

Tucker said that before the women’s center began offering the variety of services, she’d schedule her annual mammogram at Atrium and had to go to various locations for other exams.

“It’s a lot easier to schedule everything in one day. I can get everything done in one trip,” Tucker said.

Dr. Hugh Hawkins, medical director of the center, said the ultimate goal of the center is for women to lead healthier lives.

“Women who have their Pap and mammography exams are more likely to take advantage of preventative health measures: improve their diet, quit smoking,” Hawkins said.

For more information about the Women’s Center or to schedule an appointment, call (513) 420-5222 or (800) 338-4057.

—–

To see more of the Middletown Journal, or to subscribe to the newspaper, go to http://www.middletown.com.

Copyright (c) 2008, Middletown Journal, Ohio

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

New Sternal Closure Device Provides Improved Stability and Reduced Pain for Heart Patients

JACKSONVILLE, Fla., Aug. 6 /PRNewswire/ — KLS Martin LP, a medical device company specializing in craniomaxillofacial and sternal fixation, announced today the implantation of the Sternal Talon(R) in the 500th patient.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080806/CLW088 )

The Sternal Talon(R) is an alternative method of closure for midline sternotomies used in many heart procedures and utilizes rigid orthopedic-style fixation. Originally developed in conjunction with surgeons at Duke University and surgeons in Tulsa, OK, as a reconstructive alternative for patients with sternal instability and non-unions, the Sternal Talon(R) has been used successfully in primary closure for patients undergoing midline sternotomy for CABG (coronary artery bypass graft) and valvular surgery. Many of these 500 patients had multiple comorbidities, which often lead to significant infections that can be fatal. These patients represent a truly difficult population for sternal closure and until recently the cardiothoracic surgeon had very few treatment options.

“The most common method of sternal closure remains sternal wire, but this is not without problems, especially in the larger patients,” says Dr. Arch Miller, one of the inventors from Tulsa, OK. “The patients often exert forces on the wires that can cause the wires to break, pull through the bone or loosen which can lead to sternal instability, infection and increased pain.” Using the Sternal Talon(R) on patients with higher BMI (body mass index) improves the chances for better fixation, potentially reducing the risk of sternal complications and resulting in lower patient pain scores allowing them faster recovery.

“One of the most surprising outcomes of the use of the Sternal Talon(R) was the reaction of the post-operative nursing staff who commented that you could tell which patients had the Sternal Talon(R) as they were up and moving around quicker with less pain,” said Dr. Miller.

Currently, KLS Martin(R) Sternal Talons(R) are available in a select group of heart hospitals in the US. The initial experience and feedback from doctors, nursing staff and patients is very positive.

A multi-center study to evaluate the outcomes of similar high risk patients with “standard” wire closure compared to the Sternal Talon(R) is underway with the team at Duke University Medical Center and results should be available in the next 18 months. The study at Duke is being led by physicians other than those who were involved in the initial development of the Sternal Talon(R).

Additional information is available through KLS Martin LP, P.O. Box 50249, Jacksonville, FL 32246, http://www.klsmartin.com/ or http://www.rapidsternalclosure.com/ , 1-800-625-1557.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20080806/CLW088AP Archive: http://photoarchive.ap.org/AP PhotoExpress Network: PRN19PRN Photo Desk, [email protected]

KLS Martin LP

CONTACT: Jill Johnson, Sternal Talon Administrative Assistant,+1-800-625-1557 Ext 1211, [email protected]

Web site: http://www.klsmartin.com/http://www.rapidsternalclosure.com/

Further Acquisition for Schofield Media Group LLC

CHICAGO, NEW YORK, LONDON, BOSTON, Aug. 6 /PRNewswire/ — Schofield Healthcare Media Ltd, a division of Schofield Media Europe Ltd, announced on the 6th August that it has acquired Aberdeen-based HealthComm UK and its subsidiary, Continence UK.

Founded in 2004, HealthComm UK is a healthcare communications business specialising in Journal and Book Publishing, Event Management, Education and Training. The company portfolio includes a number of market leading journals and events including Wounds UK, End of Life Care, the International Lymphoedema Framework, Dermatolgy UK and Continence UK. The co-founders Edward Rusling and David Gray will continue their current roles in the business.

“Schofield Healthcare Media’s purchase of HealthComm UK reflects our shared desire to continue increasing our reach within the Healthcare sector, through providing high quality, but practical information sources for healthcare professionals,” said Edward Rusling. “Joining Schofield Healthcare Media will provide us with the opportunity to grow existing and new brands, both nationally and internationally, while also maintaining our unique clinical relationships,” said David Gray.

This transaction represents the sixth acquisition by Schofield Media Group LLC in three years, increasing the number of magazines published by Schofield Media Group to 31, of which 16 are UK-based.

Alan Freeman, Director of Schofield Healthcare Media, commented: “Following the highly successful acquisition of SB Communications in 2006 we have been looking to further strengthen our position within the healthcare sector. We feel that acquiring HealthComm UK provides us with access not only to market leading publishing/events activities, but also a strong and innovative team.”

Founder and CEO, Andrew Schofield concluded: “This is a very exciting time for our company and I expect this acquisition to support our continued growth into a leading Healthcare media company.”

Founded in 1999, Schofield Media Group publishes business-to-business magazines and operates conferences and events in the United States, Europe and Asia. The company maintains offices in London, Norwich, Aberdeen and Essex in the United Kingdom and Boston, Chicago, Seattle, Los Angeles and New York City in the United States. Divisions include Schofield Publishing, Schofield Healthcare Media, Schofield Media Chicago, Ideal Media and RedCoat Publishing. http://www.schofieldmediagroup.com/

    For further information contact:     Mike Tulloch    Managing Director    Schofield Publishing    10 Cringleford Business Centre    Intwood Road    Cringleford    Norwich    NR4 6AU    Tel: 01603 274130    Fax: 01603 274131    Email: [email protected]  

Schofield Media Group LLC

CONTACT: Mike Tulloch, Managing Director of Schofield Publishing,tel. 01603-274130, or fax, 01603-274131, [email protected]

Web site: http://www.schofieldmediagroup.com/

Nutrition From the Lab

By Grand Forks Herald, N.D.

Aug. 6–By Tom Johnson

Why do we eat? This seems like a simple question. But when I asked several people, I received a variety of answers: “To nourish my body” or “because I’m hungry” and some far-out answers loosely related to the cosmos and our place in the universe.

While the answer to the question is simple — we eat to get energy — the process of converting food into energy is complicated. The important task of converting food calories into usable forms of cellular energy is shouldered by mitochondria, specialized organelles within cells.

Mitochondria take electrons extracted from the food we eat and push them through a series of steps that ends with the production of a compound called ATP. ATP provides the energy that drives the cellular processes needed for life. But in the process of producing energy, mitochondria also produce potentially harmful substances called reactive oxygen species or ROS. While the concentration of ROS in cells usually is well-controlled, diet can influence mitochondrial function in ways that increase the production of ROS to levels that become harmful to the mitochondria.

In order to understand the relationship between diet, mitochondrial function and disease, it is important to understand how ROS can cause long-term, irreversible damage to mitochondria. Most of us know that cells have DNA that harbors the genes that determine our biological characteristics. Not as well- known is that mitochondria contain their own DNA whose genes determine the ability of mitochondria to use electrons — derived from food — to produce energy.

ROS produced by the mitochondria can damage the mitochondrial DNA. This damage can cause genetic mutations that impair the ability of mitochondria to generate energy. Over time, the accumulation of these mutations can cause mitochondria to lose their ability to produce sufficient energy to meet cellular needs, and as a consequence, disease may follow. Mitochondrial dysfunction resulting from accumulated mutations in mitochondrial DNA has been implicated in heart failure, neurodegenerative diseases such as Alzheimer’s disease, diabetes and cancer. Mitochondrial dysfunction also can contribute to obesity by causing abnormal cellular use of carbohydrates and fats.

Although the food we eat ultimately supplies the electrons that mitochondria use to produce energy, food also supplies other nutrients, particularly minerals such as iron, copper and zinc and certain vitamins, such as biotin, vitamin B6 and pantothenic acid, which support mitochondrial function. These minerals and vitamins are either components of the mechanism that mitochondria use to move electrons through the energy-producing steps or help synthesize the components in these steps.

If dietary intake of these vitamins and minerals is inadequate, electrons derived from food cannot move efficiently through the energy-producing steps. Instead of contributing to energy production, the electrons then help increase the production of ROS, which in turn increases the rate of mutations in mitochondrial genes. It is at this level, the crossroad between mitochondrial energy production and ROS production, that diet can influence the development of disease.

Research being conducted at the Grand Forks Human Nutrition Research Center is helping to determine if low intakes of nutrients needed for mitochondrial function influences the risk for developing certain kinds of heart disease and obesity.

In the U.S., a significant percentage of people — from 10 percent to 25 percent — do not meet dietary requirements for iron, zinc or vitamin B6. Furthermore, among pregnant women, 10 percent do not meet the dietary requirement for copper, more than 75 percent do not meet the dietary requirement for iron, and near 40 percent do not meet the dietary requirement for biotin.

Another important area being investigated “nutritional programming,” which occurs during gestation –where genes are turned on or off in response to various factors, including maternal diet and nutrition. Researchers are investigating whether low intakes of iron, copper or zinc during pregnancy can have long-term effects on mitochondrial function in offspring. Because such nutritional programming can affect susceptibility to health risks later in life, the researchers are studying whether such low intakes during pregnancy can promote disease as offspring age.

Recent results from studies indicate that low copper intakes by rats during pregnancy alters mitochondrial function in the hearts of offspring in a manner that increases ROS production and damage in the heart when the offspring become adults. The ultimate goal is to provide a scientific basis for dietary recommendations that will help reduce the risk for developing diseases that occur as a result of diet-related mitochondrial dysfunction.

Each month, scientists at the Grand Forks Human Nutrition Research Center write a column about their work and how their work affects people’s lives on a daily basis. This month’s column is written by Tom Johnson, research chemist. He received his doctorate from UND.

—–

To see more of the Grand Forks Herald, or to subscribe to the newspaper, go to http://www.grandforks.com.

Copyright (c) 2008, Grand Forks Herald, N.D.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Banned Words Make For Fun Research

By Martin Salazar

One might expect search terms like “democracy movement,””Tiananmen incident” and even “Playboy magazine” to be blackballed by the People’s Republic of China.

But Polynices — the Greek mythology figure who ticked off his father Oedipus so much that he was cursed to die by his brother’s hand? Yep. The ill-fated lad has somehow managed to land himself on China’s forbidden list of Internet searches.

“Polynices is, I guess, associated with anarchy in some way,” said Jed Crandall, a University of New Mexico assistant professor who is working with researchers from the University of California- Davis to unravel the ins and outs of Chinese Internet censorship. The researchers bounce potentially controversial words off Chinese Internet search engines and publish lists of the ones that apparently have been blocked.

Davis, who teaches computer science classes at UNM, began working on the project about 18 months ago while he was a graduate student at UC-Davis.

So far, the project has been a labor of love for the scientists, who have yet to get funding for the research. Crandall said two proposals have been submitted to the National Science Foundation, and they’re waiting for responses.

The Chinese use what Crandall calls a sophisticated system for censoring Internet content. Rather than blocking specific Web addresses, the system detects banned words in data moving through a network and it sends reset commands that break the connection.

The censorship could impact news coverage of the Olympic games in China, Crandall said. He noted that reporters in China could have a difficult time finding out about protests, hunger strikes or similar events because of the Internet filtering.

While China’s keyword filters are sophisticated, Crandall said, they don’t always work. Among his group’s findings is that a little more than a quarter of the paths tested into China didn’t have a filtering router, meaning the researchers were able to find the banned words. He said the filter also has a tough time preventing the searcher from accessing banned material during busy periods.

Beyond making certain content inaccessible, the goal of the censorship may also be to stop protests and perhaps even to create trade barriers for U.S. companies, Crandall said.

“There are all kinds of different reasons for censorship,” he said. “We want to understand the technical issues of censorship, how it’s implemented and then also how it’s applied so that we can make effective policy in this country.”

It takes the researchers at least a month to test the Chinese filters and figure out what is being blocked. Crandall said his research group eventually would like to be able to track banned words on a daily basis.

He said the censored list changes from time to time and that the banned words and phrases vary somewhat from one Internet service provider to another and from one region to another.

Censored phrases

These are some of the Internet phrases banned in China:

  • Eighty-nine: the year of the Tiananmen Square protest
  • Anti-corruption forum
  • Sky burial: a ritual practiced by Tibetans
  • Mein Kampf: A book by Adolf Hitler
  • Hitler: recently removed from list
  • Democracy movement
  • Brainwash
  • Eroticism
  • Playboy magazine
  • Brutal torture

Source: ConceptDoppler.org

Image Caption: Eteocles and Polynices, by Giovanni Battista Tiepolo

WellCentive Launches the WellCentive Outreach System

ATLANTA, Aug. 6 /PRNewswire/ — Atlanta-based WellCentive (http://www.wellcentive.com/) today announced the launch of its new WellCentive Outreach appointment and care reminder system, which utilizes Voice Over Internet Protocol (VoIP) technology. The WellCentive Outreach system automatically and cost effectively reminds patients about upcoming appointments or overdue care, such as mammograms and diabetic eye exams.

The WellCentive Outreach system identifies patients due for care using industry standard and/or user-specified criteria and calls them using WellCentive’s own VoIP-based network. The outreach system supports a variety of languages and will contact each patient using the primary language noted in the patient’s WellCentive chart. Reminder letters can also be generated – either manually or automatically on a scheduled basis and mailed to patients.

When a patient is contacted by the WellCentive Outreach system, a prompt is available to forward the patient directly to the doctor’s office to change, confirm or schedule appointments. The WellCentive Outreach system automatically documents attempted and successful reminder calls and tracks patient compliance and follow-up. The system can also generate reports for quality reporting purposes for insurance companies.

“The WellCentive Outreach system closes the patient outreach gap that is such a challenging part of the Chronic Care Model,” said Dr. Paul Taylor, CEO and medical director of WellCentive. “Due to a lack of resources or staffing, health care organizations are often unable to identify which patients are due for care – let alone make and track these important reminder calls. WellCentive’s Outreach system allows an organization to maintain its efficiency, while proactively and cost effectively improving the quality of care it provides.”

The WellCentive Outreach system’s capabilities and features also include:

— The capability to automatically gather scheduling and patient data using interfaces and other electronic means of capturing data

— The ability for each office to customize the script for outreach telephone calls and the text included in reminder letters

— Patient identification prompting to confirm that the system has telephoned the correct person before delivering any sensitive reminder information

— Voice recognition that allows a patient to verbally provide selections, such as a request to be forwarded directly to the physician’s office or to repeat the reminder call message

— Call system scheduling that allows each health care organization to determine how often a series of reminder calls is made and how many calls will be placed every day

— Voicemail configuration that allows each organization to decide whether a voicemail will be left for patients who don’t answer the phone

Reminder calls cost 10 cents per minute, and WellCentive offers a 300 percent return on investment guarantee for the use of the WellCentive Outreach system. An organization does not need its own VoIP telephone system, nor do the outreach calls have any effect on an organization’s telephone bill, since all calls are made via WellCentive’s own VoIP servers.

The WellCentive Outreach system is included with WellCentive’s comprehensive Web-based preventive care and chronic disease management system at no additional charge, and it is also available as a stand-alone system for a one-time set-up fee of $1,000.

“WellCentive offers a complete patient outreach and engagement system as an integral part of its patient registry system, which also includes the WellCentive Patient Portal and Secure Messaging systems,” said Dr. Taylor. “Our comprehensive registry includes a variety of reporting tools as well as the ability to easily interface with outside systems and report outcomes directly to payers. This unique combination of specialized features is what sets WellCentive apart in the marketplace.”

About WellCentive

WellCentive is a health information technology company, which offers comprehensive Web-based preventative care and chronic disease management solutions with industry-leading capabilities. The WellCentive Registry is an all-patient registry system that can be used at the point of care and can be interfaced with various disparate data sources, such as laboratories, EMR’s, billing, and scheduling systems, and with disparate data recipients, such as payers for pay for performance (P4P) initiatives and CMS for the PQRI program. In addition, WellCentive systems offer a comprehensive set of reporting tools that allow the user to design and generate a wide variety of standard and user-specified reports in a host of formats, including charts, graphs and gauges.

For more information, visit http://www.wellcentive.com/ .

WellCentive

CONTACT: Don Hunt, [email protected], or Rebecca Howe, both ofLambert, Edwards & Associates, +1-616-233-0500, for WellCentive

Web site: http://www.wellcentive.com/

HGH ICU Gets Makeover

By David Taube, Standard-Speaker, Hazleton, Pa.

Aug. 6–Tiles replaced carpets, computers replaced charts and a staff elevator replaced a single-door entrance.

These changes for the Intensive Care Unit on the third floor of the Hazleton General Hospital were unveiled Tuesday among various renovations made possible through a $132,000 grant from the state Department of Health.

Most often, HGH has received funding through federal grants, Greater Hazleton Health Alliance President and CEO James Edwards said.

“People are beginning to realize this area can service their needs,” said state Sen. Ray Musto, D-14, who secured the grant.

Edwards said sometimes it feels like southern Luzerne County is left out of the equation, so securing state funding is significant.

He presented Musto with a plaque at Tuesday’s ceremony.

“Senator Musto stepped up to help us with those funds immediately,” said Edwards, who identified these results as “otherwise unattainable.”

Musto explained that grants must justify requested need. Given a large senior citizen population, officials said, Hazleton’s demographics contributed to this award.

“People were willing to leave the area, but now things are changing,” Musto said.

The two weeks of renovations were finished in late July.

As part of the renovation, changes included a redesigned nursing station, automatic doors at the entrances, infection control tiles in place of carpets, a keycard access system, a staff elevator, privacy dividers at stations for doctors, a renovated waiting room through HGH Auxiliary funds, a fire sprinkler safety system and energy-efficient lighting, according to a press release.

Previously, the unit’s appearance may have been a cause for concern for family members of a critically ill patient, said Kim Colvell, manager of the hospital’s critical care and Stepdown units. These changes, though, make the unit more welcoming, she said.

“The changes are a call into the 21st century,” Colvell said.

Among the changes, 12 patient rooms were given a facelift. Computers now prompt nurses with instructions, and medical records are available electronically by multiple doctors and nurses inside and outside the hospital.

“It’s like having a mobile chart,” said Michael Golden, vice president of nursing.

A typical problem in medical facilities has been documents were hand-carried, and an X-ray would be on another floor.

“In this system, everyone can look at the same chart at the same time,” said Michele Cassic, director of education. Golden and Cassic also suggested that the system will boost hospital efficiency. An average patient stay of 4.8 days, they said, may also be decreased.

All patients admitted from Tuesday on will now be part of the hospital’s internal electronic database, which is accessible by family doctors and out-of-state hospitals. The system is part of a federal requirement for medical records to be paperless by 2010.

For Hazleton, these changes now bring the facility “up to par,” said Lynda Naperkowski, nurse manager of the hospital’s Gunderson Rehabilitation Center.

Many hospital officials described the area as more open. Patients and team members are now able to see all nurses at the unit’s central station due to a lowered counter that wraps around the nursing desks and stands just above waist-level.

The renovations mark the third phase of development for Hazleton General’s emergency care facilities. Previous stages included the expansion of a new emergency care area and the opening of a new operating room in 2006, both part of multi-million dollar changes.

“This grant is for the people,” Edwards said. “Even though it’s channeled through Hazleton General, it affects the 100,000-plus people in our coverage areas.”

[email protected]

—–

To see more of the Standard-Speaker or to subscribe to the newspaper, go to http://www.standardspeaker.com.

Copyright (c) 2008, Standard-Speaker, Hazleton, Pa.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Drug Czar Visits Tulare Pot Site: New Program Will Raid Marijuana Gardens of Mexican Drug Cartels.

By Lewis Griswold, The Fresno Bee, Calif.

Aug. 6–The nation’s drug czar chopped down marijuana plants growing deep inside the Sequoia National Forest in Tulare County on Tuesday.

John Walters, who holds the Cabinet-level position as director of the White House Office of National Drug Control Policy, came to California to bring attention to a new locally coordinated, but partly federally funded, marijuana eradication program to raid marijuana gardens planted on public lands by Mexican drug cartels.

“We intend to shoot these down,” Walters said.

U.S. Attorney McGregor Scott joined Walters in a helicopter ride to a remote location to remove plants, then both spoke at a news conference in Visalia.

Scott said those arrested for growing 1,000 or more marijuana plants on public lands face minimum 10-year terms.

Mandatory minimum sentences “make criminals talk,” Walters said approvingly.

“Talking criminals is what you need to go after the higher-ups.”

Mexican drug cartels are coming to the United States to grow marijuana because of tightened border security, Walters added.

The new program the drug czar came to Tulare County to highlight has been dubbed Locating Organized Cannabis Cultivators Using Saturation Tactics. It involves 14 federal state and local law enforcement agencies, each contributing personnel and equipment, and is coordinated by the Tulare County Sheriff’s Department. The department received a $200,000 grant from Office of National Drug Control Policy to find “grow sites” and raid them.

The raids, using helicopters from the Air National Guard and involving about 220 law enforcement agencies, have targeted 63 gardens, the Sheriff’s Department said. An additional 20 sites have been identified, but are still to be raided. The operation started in late July and will continue until all have been raided, officials said.

So far, 340,685 plants have been discovered, and 36 people arrested. Most of those arrested for cultivating marijuana on federal lands are Mexican nationals, Scott said.

Walters said public perception that marijuana is harmless is out of date. Marijuana addiction is a major problem for young people today.

“For those of the baby boomer generation who started this stupidity, I want you to know this is not the marijuana of the 1980s,” he said. The marijuana being eradicated in national parks “is not something raised by some retired hippie.”

The reporter can be reached at [email protected] or (559) 622-2416.

—–

To see more of The Fresno Bee, or to subscribe to the newspaper, go to http://www.fresnobee.com

Copyright (c) 2008, The Fresno Bee, Calif.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Chattanooga: Young People Protest Rumored Abortion Clinic

By Emily Bregel, Chattanooga Times/Free Press, Tenn.

Aug. 6–The ruckus over a rumored abortion clinic in Chattanooga continued Tuesday as dozens of young people who oppose abortion gathered to protest.

The event took place at the supposed future site of an abortion clinic on Hixson Pike. Young people ranging from about age 3 to the late 20s attended.

The protest was organized by Charles Wysong, president of the American Rights Coalition, a Chattanooga-based advocacy group that gives counseling and support to women who have had abortions and has protested the rumored clinic in recent weeks.

Sixteen-year-old Stephen Wysong, son of Charles Wysong, said the group, called Teenagers Against Abortion, aimed “to tell the abortion clinic, or whoever’s opening it, that he’s not welcome here, and we just don’t want an abortion clinic here in Chattanooga.”

Abortion-rights supporters said prevention of unwanted pregnancies is a more effective way to decrease abortion rates.

“We think it would be a much more effective use of time and energy rather than protesting a hypothetical clinic … to join us in our efforts to prevent unintended pregnancy through access to medically accurate sexuality education and contraception services,” said Mark Huffman, vice president of organizational development for Planned Parenthood of Middle and East Tennessee, based in Nashville.

Controversy over a rumored abortion clinic began in July when abortion opponents here noticed a Web site claiming that such a clinic was coming to Chattanooga, which has not had an abortion clinic since the early 1990s.

The Web site — www.tnabortion.com — previously said a clinic would be opening in Chattanooga in August but now simply lists a number for Chattanooga.

Local abortion opponents say that Charlotte, N.C.-based Preferred Woman’s Health Center intends to open the clinic at 4066 Hixson Pike, but employees at Preferred Woman’s have denied that they intend to move to Chattanooga.

Multiple calls placed to Preferred Woman’s Health Center on Tuesday were transferred to a voice-mail system.

Abortion clinics typically are licensed as ambulatory surgical treatment centers and require a certificate of need from the state health department to be licensed. So far, no certificate of need has been filed with the state to open such a facility in Hamilton County, Jim Christoffersen, deputy general counsel for Health Services Development Agency, said Tuesday.

The process to get approval for a certificate of need typically takes at least 120 days, state health officials have said.

Members of Teenagers Against Abortion, also called Teenagers for an Abortion-Free Chattanooga, said the group plans to open chapters in the other cities in which Preferred Woman’s Health Center has clinics — Augusta, Ga.; Raleigh, N.C.; and Charlotte.

—–

To see more of the Chattanooga Times/Free Press, or to subscribe to the newspaper, go to http://www.timesfreepress.com.

Copyright (c) 2008, Chattanooga Times/Free Press, Tenn.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Bayer Diabetes Care Partners With Nick Jonas to Encourage Young People to Proactively Manage Their Diabetes

TARRYTOWN, N.Y., Aug. 6 /PRNewswire/ — Today, Nick Jonas, the youngest member of the Jonas Brothers established his role as a diabetes ambassador by launching a new partnership with Bayer Diabetes Care to provide young people and their families with the motivation and support they need to help simplify life with diabetes.

At a press conference today in New York City, Nick and Bayer kicked off their long-term partnership, with Bayer making an initial large donation to the Change for the Children Foundation to support Nick’s goal of helping children with diabetes. The Foundation is a Jonas Brothers organization that provides support to programs that motivate and inspire children to face adversity with confidence, determination and a will to succeed. The partnership will provide resources and information over the next few years specifically designed for young people with diabetes to help them simplify their lives and successfully manage their disease.

Nick, diagnosed with type 1 diabetes at age 13, is passionate about sharing his personal story because he knows so many young people like him can feel alone and even embarrassed by the disease. It’s important to Nick to take what he’s learned and what works for him and pass it along to others who may be feeling the same way.

“Nearly every day I hear from someone like me who says that I make them feel it’s OK to have diabetes and that’s really cool that I can do that,” said Nick Jonas. “I know I’m lucky because I have a family that encourages me a lot. I want to give that same inspiration to other kids with diabetes, and working with Bayer lets me do that.”

Bayer and Nick share a common goal of helping people with diabetes simplify their lives by achieving “Simple Wins”: small, everyday victories for managing the disease that can lead to big differences over time. For Nick, a Simple Win is about making other kids with diabetes feel like they can live their dreams and have a positive outlook.

“Nick is a deeply passionate role model for young people with diabetes and their families, and Bayer shares in his dedication,” said Sandra Peterson, President of Bayer Diabetes Care. “Bayer believes Nick can play a significant role in encouraging all people with diabetes, no matter how young or old, to be proactive in managing their diabetes to live their lives to the fullest.”

Through the partnership, young people with diabetes and their families can log on to http://www.nickssimplewins.com/, where they can check out more about Nick’s personal experiences. Nick will be blogging about his latest activities, giving updates on chances to meet him in person and sharing ideas on how to achieve Simple Wins. Also available to download is “A Little Bit Longer,” a new single released yesterday and the title track to the Jonas Brothers’ upcoming album. Nick wrote this song when he was having a particularly hard day managing his diabetes and feels supported when his fans sing along to the lyrics.

“I’m so proud of Nick’s incredibly positive attitude and his sense of responsibility to give back to other people with diabetes,” said Nick’s mom, Denise Jonas. She plans to be involved in the program, working with her family to help provide information and encouragement to other families living with diabetes.

Diabetes is a disease where the body doesn’t produce or properly use insulin. Insulin is the hormone that converts sugar, starches and other food into the energy needed to live. According to the Centers for Disease Control, diabetes is one of the most common chronic diseases among children in the United States. About 150,000 young people under 18 years of age have diabetes.

Type 1 diabetes, also called juvenile diabetes, is usually diagnosed in children and young adults. With type 1 diabetes, your body makes little or no insulin, which may result in many complications if glucose levels are not controlled.

Nick uses the new Bayer CONTOUR(R) meter to test how much glucose or sugar is in his blood so he can determine how much insulin he needs as well as to see how his treatment regimen is working. It’s the first thing he learned about managing his condition. CONTOUR Colors meters will be available soon in Green Apple, Royal Purple and Graphite Gray — to fit everyone’s individual style.

“I check my blood sugar level up to 12 times a day so it’s very important that my meter fits with my lifestyle,” said Nick. “My new Bayer CONTOUR meter lets me personalize the settings when I need to test myself before a meal or reminding me to check after a meal, for example, depending on my schedule on a specific day.”

About Change for the Children Foundation

The Change for the Children Foundation is a Jonas Brothers organization that provides support to programs that motivate and inspire children to face adversity with confidence, determination and a will to succeed. The Jonas Brothers believe that the best people to help children are their peers, and the foundation provides opportunities for kids to help other kids who are a little less fortunate.

“YOU Decide. YOU Donate.” is a current initiative of The Change for the Children Foundation. The Jonas Brothers have selected five charities and are calling on kids to decide which one to support.

D-Vision is Nick Jonas’ part of the Change for the Children Foundation. Its goal is to support people with diabetes and help raise money and awareness to research a cure. http://www.changeforthechildren.org/

Bayer HealthCare, Diabetes Care

Bayer HealthCare, Diabetes Care is a worldwide leader in diabetes, supporting customers in 100 countries. Since the introduction of CLINITEST(R) reagent tablets in 1941, Bayer has led the way in diabetes care product innovation. The company changed the face of diabetes care in 1969 when it introduced the first portable blood glucose meter and test strips. Bayer HealthCare further innovated diabetes management by being the first company to introduce a suite of blood glucose monitors with No Coding(TM) technology. The BREEZE(R)2 and CONTOUR(R) blood glucose monitoring systems offer people with diabetes an unparalleled choice in diabetes management systems. The Arthritis Foundation in the United States and the Arthritis Society of Canada each granted Ease-of Use Commendation to the BREEZE(R)2 meter. BREEZE(R) represents the first time a blood glucose meter has been recognized as easy to use for arthritis sufferers.

In July 2006, Bayer Diabetes Care acquired Metrika Inc., maker and manufacturer of A1CNow+, a meter-based diabetes monitoring system for measurement of A1C (glycated hemoglobin) an important indicator of long term blood sugar control. Bayer HealthCare, Diabetes Care global headquarters is located in Tarrytown, New York, in the United States and operates as part of Bayer HealthCare LLC, a member of the worldwide Bayer HealthCare group. http://www.bayerdiabetes.com/us

Bayer HealthCare

Bayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide.

This news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to inform them to future events or developments.

Bayer Diabetes Care

CONTACT: Staci Gouveia, office +1-914-366-1819, cell +1-203-809-9008,[email protected], or Susan Yarin, office +1-914-366-1738, cell+1-914-479-7589, [email protected], both of Bayer Diabetes Care

Web site: http://www.bayerdiabetes.com/ushttp://www.nickssimplewins.com/http://www.changeforthechildren.org/

Board Hires CompleteRx

By Geoff Folsom, Odessa American, Texas

Aug. 6–The Ector County Hospital District Board of Directors voted Tuesday to hire CompleteRx of Houston to manage Medical Center Hospital’s pharmacy.

The three-year contract will pay the company $72.27 per patient day, or an estimated $5.8 million a year, Peter Snell of CompleteRx said. In exchange, the company will provide MCH with prescription drugs, two pharmacists and a buyer.

The deal will save MCH an estimated $465,000 annually, said hospital chief operating officer Tony Ruiz.

In an evaluation, CompleteRx rated MCH’s pharmacy a “four,” on a scale of “one” being the best and “five” being worst.

The evaluation showed MCH was meeting minimum standards, but its drug cost trends more than doubled industry inflation, Snell said.

“Wow, this is an eye opener,” board member Mary Thompson said. “I think it would be negligent if we didn’t do this.”

The program would benefit MCH by guaranteeing drug costs at a certain level, Snell said.

Bill Webster, MCH chief executive officer, said the agreement would help the pharmacy better communicate with doctors and nurses.

“I think we have a very good pharmacy,” he said. “I think we can make it a lot better pharmacy.”

The board also approved modernization of four elevators near the hospital’s main entrance for $647,118. The project is the second part of a five-year plan to renovate all 27 elevators at MCH.

The project, which will take one elevator out of service at a time, will install new controllers, machines, signals and hoist way wiring.

In executive session the board approved five ProCare physician contracts with pulmonary critical care Dr. Moises Cossio ($400,000 per year), adolescent medicine Dr. Marcela Nur ($224,800), internal medicine for women Dr. Adriana Nur ($220,000), anesthesiologist Dr. Luke Young and wound care/family practice Dr. Eduardo Salcedo ($220,000).

In other action, the board approved:

–A regional UPL Resolution.

–A two-year cardiovascular perfusionist agreement for $390,000.

–A letter of engagement with the Hammes Company for an ambulatory care center at the planned project at MCH’s development in Northeast Odessa.

–An American Express Corporate Card Program that gives the hospital a $4.8 million credit line and gives up to a 1 percent cash rebate with certain vendors.

–Medical Equipment Management System, software and hardware for $128,283.

–A nurse paging system for $281,768.

—–

To see more of the Odessa American, or to subscribe to the newspaper, go to http://www.oaoa.com.

Copyright (c) 2008, Odessa American, Texas

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

NutriPure Beverages, Inc. Clarifies Stock Situation

NutriPure Beverages, Inc. (Pink Sheets:NUBV) announced today that despite rumors to the contrary, NutriPure has not filed for a reverse stock split and has no immediate plans to do so. NutriPure Chairman and CEO Kenyatto Jones commented as follows: “It has come to our attention that rumors are circulating on Internet chat boards that NutriPure has filed for a reverse split of its common shares. In fact, no such filing has been made, nor is that issue under discussion or being contemplated at this time. These rumors have most likely come about as a result of the large increase in the company’s trading volume over the past week or so. We will always make decisions based on what we feel is in the best interest of the company and its shareholders. Our next Board meeting is scheduled for mid-September and at that time our Board will decide what further action, if any, should be taken in this matter. Meanwhile, we are very pleased with the recent activity and liquidity of our stock, and are very busy with our activities regarding XND Technologies, Inc. and Moneymaker 1 LLC. We expect to be releasing additional information about these ventures over the next few days.”

ABOUT NUTRIPURE BEVERAGES, INC.

NutriPure Beverages, Inc. (NUBV.PK) is bringing to market a complete line of NU2O nutrient-enhanced bottled water products, using a patented technology that is more efficient and less costly than any other currently in use. This unique process adds organic nutrients to water without adding masking flavors, colors or sweeteners, yielding premium enhanced water products that contain no calories, no carbohydrates, no colors and most importantly, no flavors other than pure water. The process is further enhanced using desirable “cold-fill” techniques, which save energy and reduce harmful, “plastic chemical leaching” into the product. Nu2O products will compete with currently available products such as VitaminWater and SmartWater, and will include formulas that provide vitamin support for general health, a diet formulation for weight watchers, an immune booster, an energy and fitness drink, and additional products to be announced later. NutriPure is also seeking additional acquisitions and ventures in the “healthy water/healthy food” industry.

For more information visit www.nutripurebeverages.com.

Safe Harbor Statement: This release contains forward-looking statements with respect to the results of operations and business of NutriPure Beverages, Inc., which involves risks and uncertainties. The Company’s actual future results could materially differ from those discussed. The Company intends that such statements about the Company’s future expectations, including future revenues and earnings, and all other forward-looking statements be subject to the “Safe Harbors” provision of the Private Securities Litigation Reform Act of 1995.

Lilly Sells Its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies

INDIANAPOLIS, Aug. 6 /PRNewswire-FirstCall/ — Eli Lilly and Company today announced that Covance Inc. , one of the world’s leading drug development services companies, will buy and operate Lilly’s Greenfield Laboratories located in Greenfield, Indiana. In addition, Lilly is finalizing plans to lease a new worldwide headquarters for its animal health division, Elanco, in Hancock County, Indiana. The announcement is part of a series of actions the company is taking to restructure its research and development organization in order to compete in a dramatically changing environment.

These moves will help improve productivity by gaining speed to market and lowering drug development costs, while supporting the continued growth of Elanco.

“For nearly a century, Greenfield Laboratories has been an important Lilly site, currently housing Elanco’s worldwide headquarters and a significant portion of Lilly’s toxicology testing, as well as other R&D support functions,” said John Lechleiter, Ph.D., Lilly’s president and chief executive officer.

“These actions reflect Lilly’s determination to take the necessary steps to compete in a very challenging marketplace, in which our customers are demanding innovative, high-quality, affordable medicines. These are difficult but necessary decisions we must make in order to compete successfully as an independent Indiana-based company,” Lechleiter added.

Covance to buy Lilly’s Greenfield Laboratories

Lilly will sell its Greenfield Laboratories site and transfer operations to Covance for an up-front payment of $50 million. The two companies also will sign a 10-year service agreement. Under this agreement, Lilly and Covance will broaden their existing strategic collaboration, with Covance assuming responsibility for Lilly’s toxicology testing and other R&D support activities at the site. Covance currently conducts significant preclinical toxicology and early-stage clinical work for Lilly. This collaboration, which also includes expanded early-stage clinical work and Phase II/III clinical trial support, will help Lilly to lower drug development costs and speed the flow of new medicines.

Joe Herring, Covance chairman and chief executive officer, added, “Our longstanding relationship with Lilly has delivered innovation in the safety and efficacy testing of new prescription drug candidates, and it sets the stage for this landmark agreement. Through the years, we have demonstrated significant success in expediting early development timelines and improving efficiency.”

“This expanded agreement creates a new strategic paradigm at a time when the pharmaceutical industry needs to challenge traditional thinking in order to improve its R&D productivity. We are confident that this alliance will help create strategic competitive advantages for Lilly and allow Lilly to strengthen its focus on its core competencies,” Herring said.

“We are also very pleased to expand our employee base in Central Indiana, which has a strong life sciences talent pool and has long been a successful home for our global central laboratory and bioanalytical businesses,” he said.

Upon the deal’s closing, Covance will assume control of the Greenfield site and most of its operations. About 260 Lilly employees are impacted by the sale of the site. These employees will receive an offer of a position with Covance or will have the opportunity to apply for limited roles within Lilly. Employees who depart Lilly will each receive a competitive severance package. An additional 225 Lilly employees currently based in Greenfield will move to Lilly sites in Indianapolis.

New Elanco Worldwide Headquarters

To support Elanco’s business needs, the company plans to lease a new, expanded headquarters in Hancock County, Indiana. Construction will commence upon final site selection, completion of plans with the developer, and receipt of local government approvals. The facility is scheduled to be completed in late 2009 or early 2010.

While the facility is being built, Lilly will lease most of Elanco’s current space from Covance. Elanco’s more than 350 employees will move to the new global headquarters when construction is complete.

“In recent years, Elanco has expanded in both sales and product offerings, posting record revenues of nearly $1 billion in 2007. Elanco also recently launched the Lilly Companion Animal Health division and acquired Ivy Animal Health,” said Elanco President Jeffrey N. Simmons. “As we’ve grown, however, the current configuration of Greenfield Laboratories no longer supports Elanco’s needs. The new Elanco headquarters will centralize the division’s operations, while offering significant savings in annual operating expenses.”

Lilly Center for Medical Science at Indiana University Medical Center

As a part of the agreement with Covance, Lilly has committed to conducting additional Phase I clinical trials with Covance. Because Covance operates a clinic in Evansville, Indiana, that is similar to the Lilly Center for Medical Science (formerly the Lilly Clinic) the volume of work at the Lilly Center will be substantially reduced and it will most likely be closed. The Center’s 48 employees will have the opportunity to apply for roles within Lilly or receive a competitive severance package.

U.S./Puerto Rico Clinical Trial Monitoring; U.S. Data Management

In addition to the Covance arrangement, other restructuring activities are also being announced. Lilly will transfer its clinical trial monitoring work in the United States and Puerto Rico to Quintiles, the world’s largest pharmaceutical services company, and the majority of its data management work in the United States to i3, a full-service, global clinical research organization.

Approximately 265 Lilly employees, some of them based outside Indianapolis, will be affected by these changes. Lilly has new positions for about half of these employees; the remaining impacted employees will receive a competitive severance package from Lilly and can also pursue employment opportunities with Quintiles or i3.

Financial Impact

Inclusive of all of these actions, Lilly expects to incur asset impairment and restructuring charges that likely will be significant; however, it is premature to estimate the size or timing of these charges at this time.

About Lilly’s Transformation

Over the past several years, Lilly has been transitioning to a new, more networked business model by increasing collaboration with organizations outside the company’s walls to generate ideas and build capabilities, sell products, reduce costs, manage risk, and accelerate productivity. These collaborations include many businesses and academic institutions in Indiana.

“What we call Years YZ — the period beginning in late 2011 when patents for several medicines begin to expire — requires a thorough transformation of our company that includes reduced cycle times and lower R&D costs,” said Lechleiter. “As we act decisively, we aim to implement these changes with utmost respect for our employees and continued support for the communities in which Lilly operates.”

Consistent with Lilly’s transformation strategy, restructuring of research and development operations will reduce fixed costs and increase Lilly’s ability to speed innovative medicines to patients. Specifically, the sale of Greenfield Laboratories to Covance underscores Lilly’s commitment to growing the life sciences sector in Indiana by partnering with a knowledge-based bioscience company and keeping jobs in the state.

“Nowhere is Lilly’s network strategy more pronounced than in Indiana, where more than 3,000 firms support the company’s work in both national and global markets,” said Lechleiter. “Through this collaboration with Covance and others, Lilly will help enhance the region’s life sciences sector, expanding Lilly’s economic footprint in Indiana as never before. Specifically, these partnerships will result in no net job reductions in the state — and they will offer the potential for new jobs in the future. Throughout this process we have worked to put Lilly employees and Indiana first.”

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Indiana, Lilly provides answers — through medicines and information — for some of the world’s most urgent medical needs. Additional information about Lilly is available at http://www.lilly.com/ .

About Covance

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies with annual revenues greater than $1.5 billion, global operations in more than 20 countries, and more than 9,000 employees worldwide. Information on Covance’s products and services, recent press releases, and SEC filings can be obtained through its website at http://www.covance.com/ .

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, [email protected]

Eli Lilly and Company

CONTACT: Christine Van Marter, +1-317-651-1473, or Angela Sekston,+1-317-276-5046, both of Eli Lilly and Company; or Joan Todd of Elanco,+1-317-277-7464

First DuraHeart(TM) Left Ventricular Assist System Implanted in the U.S. Pivotal Trial

ANN ARBOR, Mich., Aug. 6 /PRNewswire/ — Terumo Heart, Inc. announced that the first U.S. implant of the DuraHeart(TM) Left Ventricular Assist System (LVAS) took place on July 30 at the University of Michigan Cardiovascular Center in Ann Arbor, Michigan. The surgery was performed by Francis Pagani, M.D., Ph.D. National Co-Principal Investigator for the DuraHeart U.S. Pivotal Trial. DuraHeart is the world’s first third generation left ventricular assist system combining a centrifugal pump with a magnetically levitated impeller to enter clinical trials in the U.S.

“The DuraHeart gives us a new, third-generation option for patients with advanced heart failure who need help to allow them to survive until they can receive a heart transplant,” says Pagani, who leads the U-M Center for Circulatory Support.

Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo Heart, Inc., said, “The first patient in the United States is an important initial step in the pivotal trial. This patient is the 71st patient worldwide since the DuraHeart European investigational trials began in 2004. We have had exceptional outcomes in Europe and look forward to similar outcomes in the U.S.” In clinical results as of July 31, 2008, patient support averaged 223 days with cumulative support of 43 years. The longest ongoing patient support is over three years.

The DuraHeart LVAS Pivotal Trial is a multi-center, prospective, non- randomized study of 140 patients and will include up to 40 centers. The device is intended to provide cardiac support for patients awaiting transplant who are at risk of death due to end-stage left ventricular heart failure. Yoshifumi Naka, M.D., Ph.D., from Columbia Presbyterian Hospital in New York, will serve as the National Co-Principal Investigator with Dr. Pagani.

Dr. Nojiri added, “We are excited at the prospect of making this state of the art technology readily available for the increasing need of heart failure patients. Third generation systems are anticipated to demonstrate improved outcomes and long term reliability. DuraHeart is the most advanced third generation centrifugal pump by virtue of the magnetically levitated impeller, positioning us for a leadership role in the future treatment of heart failure.” In addition to the U.S. trial, Terumo Heart is expected to initiate clinical trials in Japan this year.

Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in Ann Arbor, Michigan. The company’s focus is the innovation and introduction of products to improve the quality of healthcare for heart failure patients. Terumo Corporation, headquartered in Tokyo, Japan, is a leading developer, manufacturer and global marketer of a wide array of medical products. DuraHeart is limited to investigational use only in the United States, and is CE marked in Europe.

http://www.terumoheart.com/

Terumo Heart, Inc.

CONTACT: Carmen Fox, Senior Marketing Communications Specialist, TerumoHeart, Inc., +1-734-741-6345, [email protected]

Web site: http://www.terumoheart.com/

Hospital Directors Say Patients Won’t Notice Difference

By Ben Wolfgang, Republican & Herald, Pottsville, Pa.

Aug. 6–The changes won’t be obvious to patients — at least for now.

“Most likely, there will be no bed elimination,” John Simodejka, president/CEO of the newly formed Schuylkill Health System — the product of an affiliation between Good Samaritan Regional Medical Center and Pottsville Hospital and Warne Clinic — said Tuesday. “There is no anticipated layoff among staff. This is not a takeover. This, from day one, has been a partnership.”

Simodejka, along with board of directors Chairman Judge Joseph F. McCloskey and Vice Chair Judge William E. Baldwin, sat down with The REPUBLICAN & Herald on Tuesday to answer lingering questions about the reasons for and results of the recent “merger” between the two hospitals.

Medical operations at both locations will remain largely the same, but Simodejka said the affiliation will provide better, more thorough service in the future.

Patients, he said, will be unaffected by the move right now. In the future, he said, the effects will be positive, with the merger allowing advances in medical equipment.

Also, financial problems with the two hospitals were not a factor in the decision, hospital officials said.

Simodejka said the affiliation was made official late last week, with Good Samaritan now known as Schuylkill Medical Center-East Norwegian Street and Pottsville Hospital now known as Schuylkill Medical Center-South Jackson Street.

The new health system has about 1,900 employees and a combined 359 beds.

Many questions remained since the two hospitals announced a “letter of intent” to merge operations in September 2007. In the months following, the flow of information was scarce and, at times, non-existent.

“Could we have done better? Yes,” Simodejka said, but said he felt media coverage of the matter could have also been better.

Catholic presence

The Schuylkill Health System has no religious affiliation. The cross was removed from the former Good Samaritan Regional Medical Center last week, but Simodejka said he isn’t fearful of a backlash from area Catholics.

“I believe most people do not make their decision where they go for health care based on religious affiliation,” Simodejka said. “They make it based upon the doctor and the staff that will take care of them — at least, that’s what they should be making it on.”

Good Samaritan was previously sponsored by the Daughters of Charity and associated with Ascension Health, St. Louis — the largest nonprofit Catholic health system in the country.

“The Daughters of Charity participated in this whole decision,” Baldwin said. “They reached the decision that the best way to fulfill their mission of health care in the community was for the two hospitals to get together. We do that with their blessing, their support.”

Area Catholics, however, have fond memories of the nuns and their unique work at Good Samaritan. “We always did go to Good Sam,” Mary Luppino, 78, of Pottsville, a lifelong Catholic, said Tuesday. “We lost a baby in the 1960s and the nuns were the ones who broke the news to me. And the beautiful way they did that — you wouldn’t get that today.”

Luppino said she expects this generation of Catholics may not be as reluctant to seek care at a nonreligious hospital.

Older Catholics, however, will have to get used to it.

“They won’t have much of a choice, unless you want to go out of town,” Luppino said. “And who wants to do that?”

The decision also comes on the heels of a massive parish restructuring in Schuylkill County, which hospital officials said is in no way related to the hospital affiliation.

Pottsville Hospital was established in 1895. Good Samaritan was established in 1920.

Business as usual

Medical operations will continue as usual at both locations.

In the future, Simodejka said, management will look at ways to reduce duplication of services.

“Nothing has been consolidated as of yet,” he said. “We will be, in the first 30 to 90 days, looking at some items that have made sense (to consolidate). But also, we’ll be continuing that process over the next 90 to 180 days.”

Patients will continue to have a choice of which facility to visit during emergencies.

“Emergency departments will stay open at both locations,” Simodejka said. “We couldn’t combine them into one location even if we stacked them and packed them. We don’t have the financial resources to put $10 million into building a new emergency department.”

Also, Simodejka said any outstanding bills owed to either former hospital are now owned to Schuylkill Health System.

Due diligence

Between September 2007 and April 2008, the hospitals undertook a “due diligence” process, during which time little information was released.

“It was basically the time period when you’re allowing the other side to look at the other side without any blinders on,” he said, but added it was mostly “lawyers and consultants” doing the looking, not management from either hospital.

Late last week, a state attorney general investigation into the affiliation was completed and gave the green light.

Still, Simodejka said he kept details under wraps for employees’ sake.

“The reason the announcement didn’t go out on (July) 31st or (Aug.) 1st — that was an internal decision made by me and the board of directors,” he said. “I thought it was very important I speak to the employees myself, personally. I did not want to have them hear it through an e-mail or letter.”

He described the reaction of both employees within each facility and outside doctors associated with Schuylkill Health System as “very, very positive.”

Money not problem

The reasons — as each hospital stressed when the letter of intent was announced — have nothing to do with current financial issues.

“This has to do with financials for the future, not current financials,” Simodejka said, adding neither hospital was losing money in the years leading up to the merger.

McCloskey said the move will allow both facilities — both are still separately licensed with the state Department of Health — to put money together, giving greater flexibility when buying equipment and expanding services.

“What the attorney general really is saying, when he said there is no problem with the merger, is there is good competition and there is bad competition,” McCloskey said. “If the competition gets to the point where it’s stretching the resources (of either hospital), therefore money cannot go into better health care.”

Also, the move has been constantly referred to as an “affiliation” — not a merger — by hospital management.

On Tuesday, McCloskey and Baldwin acknowledged that the subtle difference in semantics fell on deaf ears, at least in the public.

“For practical purposes, it is a merger,” Baldwin said.

The new board

The Schuylkill Health System board of directors includes seven members from each former hospital board.

Board members from the former Pottsville Hospital board are: Debra C. Blaschak, William L. Jones III, Allen E. Kiefer, Jay M. Linard, Franklin K. Schoeneman, Robert M. Zimmerman and McCloskey.

Board members from the former Good Samaritan board are: Jesse C. Achenbach, Anthony Baran, Sarah T. Casey, James T. Gallagher, William E. Kirwan, Syed Shah and Baldwin.

Those 14 picked Judy K. Schmidt — human resources manager at SAPA Industrial Extrusions, Cressona — as the 15th member.

M. Michael Peckman, former spokesman for Pottsville Hospital, is now the Schuylkill Health System spokesman. Former Good Samaritan spokeswoman Michelle Canfield is no longer associated with the organization.

—–

To see more of the Republican & Herald or to subscribe to the newspaper, go to http://www.republicanherald.com.

Copyright (c) 2008, Republican & Herald, Pottsville, Pa.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Tolerx Initiates Dosing of Otelixizumab, a Novel Type 1 Diabetes Agent, in DEFEND, a Phase 3 Clinical Trial

CAMBRIDGE, Mass., Aug. 6 /PRNewswire/ — Tolerx, Inc., a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases, today announced the initiation of a pivotal Phase 3 clinical trial that is evaluating otelixizumab in autoimmune new onset type 1 diabetes. As a result of the initiation of patient dosing in DEFEND (Durable Response Therapy Evaluation For Early or New Onset Type 1 Diabetes), Tolerx will receive a $15 million milestone payment from GlaxoSmithKline.

DEFEND is a randomized, placebo controlled Phase 3 trial designed to enroll approximately 240 adult patients, age 18 to 35, with newly diagnosed autoimmune type 1 diabetes. DEFEND is being conducted at multiple centers in North America and Europe. The trial will evaluate whether a single course of otelixizumab, administered not more than 90 days after the initial diagnosis of autoimmune type 1 diabetes, will reduce the amount of administered insulin required to control blood glucose levels by inhibiting the destruction of beta cells. The primary endpoint will be a measurement of C-peptide, a surrogate measure of beta cell function. Maintenance of beta cell function has been associated with improved glycemic control (HbA1c levels), fewer hypoglycemic events, and a reduction in long-term disease complications in established type 1 diabetics in the Diabetes Control and Complications Trial (DCCT).

“We are excited to have dosed the first patient in DEFEND and look forward to continued patient enrollment in this Phase 3 clinical trial. The initiation of DEFEND represents the culmination of a methodical, dose-ranging development plan, including the successful outcome from an end-of-Phase 2 meeting at FDA. We believe otelixizumab has the potential to provide an important new treatment option for patients with newly diagnosed autoimmune type 1 diabetes,” said Dr. Douglas J. Ringler, President and Chief Executive Officer of Tolerx.

For additional information about DEFEND, please visit http://www.defendagainstdiabetes.com/.

About Type 1 Diabetes

Diabetes (medically known as diabetes mellitus) is the name given to disorders in which the body has difficulty regulating its blood glucose (sugar) level. There are two major types of diabetes: type 1 and type 2. Type 1, previously known as juvenile diabetes or insulin-dependent diabetes, is a disorder of the body’s immune system. In type 1 diabetes, the immune system attacks and destroys the insulin-producing beta cells in the pancreas. The decrease in endogenous (natural) insulin production means that patients must monitor their glucose levels frequently and take insulin regularly to control their blood glucose levels.

About Otelixizumab

Otelixizumab is a monoclonal antibody that binds to CD3, a T lymphocyte receptor involved in normal cell signaling. Otelixizumab is thought to work by blocking the function of effector T cells that attack the body’s tissues and cause autoimmune disease while inducing a subset of T cells known as regulatory T cells. It is thought that the regulatory T cells may protect against effector T cell damage well after the antibody has been eliminated from the body. In addition to DEFEND, Tolerx is also continuing to evaluate otelixizumab in subjects with type 1 diabetes in its ongoing Phase 2 study, TTEDD (TRX4 Therapeutic Evaluation of Different Dosing Regimens). A principal purpose of TTEDD is to evaluate different dosing regimens in an effort to reduce side effects and to acquire additional information about otelixizumab’s clinical activity. Tolerx has conducted dose optimization studies in type 1 diabetes and has identified a dosing regimen that thus far has significantly reduced side effects while maintaining important biological activity. This dosing regimen is being used in DEFEND. For more information on DEFEND, please see http://www.defendagainstdiabetes.com/.

Tolerx Collaboration with GlaxoSmithKline

In October 2007, Tolerx and GlaxoSmithKline (GSK) entered into a global alliance to develop and commercialize otelixizumab in numerous indications, including type 1 diabetes. Under the terms of the agreement, Tolerx is responsible for conducting the Phase 3 clinical program for type 1 diabetes in the US and if successful, for submitting the biologics license application (BLA) to the FDA. Tolerx has the option to co-promote otelixizumab in type 1 diabetes in the US with GSK while GSK has exclusive rights to develop and commercialize otelixizumab in all other indications worldwide, including pediatric type 1 diabetes.

About Tolerx

Tolerx is a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. Tolerx currently has two antibodies in clinical development: otelixizumab and a modified version of TRX1, MTRX1011A. MTRX1011A is a humanized anti-CD4 monoclonal antibody being developed in collaboration with Genentech, Inc. Tolerx is also engaged in preclinical development of new monoclonal antibody product candidates that engage the body’s immune system and promote and enhance immune responses. These antibodies are being assessed for potential benefit in the treatment of cancer, chronic viral diseases, and as an adjunct to vaccines. For more information, please visit http://www.tolerx.com/.

Tolerx Forward-Looking Statements

This press release contains certain statements that are preceded by, followed by, or that include the words “will evaluate,””will,””look forward,””believe,” and “has the potential to,” or similar expressions or the negation thereof. Such statements, which are not historical facts, constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Statements regarding the outcomes sought to be realized in the Phase 3 clinical trial, the possibility that otelixizumab may have the potential to change type I diabetes treatment paradigms, the anticipated progress and development of otelixizumab, in type 1 diabetes and other disease indications, are all forward-looking statements. Such forward-looking statements involve risks, uncertainties and other factors that may cause the actual performance or achievements of Tolerx to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Factors and risks that may impact management’s expectations and affect the forward-looking statements shall include but not be limited to results of DEFEND and other future clinical studies, the ability to obtain regulatory approval for otelixizumab for type 1 diabetes or any other indication, the continuation of the collaboration with GSK, the introduction of competing therapies by other companies, and changes in the company’s business plan or objectives. These statements reflect the view of Tolerx as of the date of this press release and should not be relied upon as reflecting the company’s views at any date subsequent to this release. Tolerx undertakes no obligation to update or revise any forward-looking statements to reflect events or circumstances after the date of this press release.

Tolerx, Inc.

CONTACT: Cory Tromblee of Tolerx, Inc., +1-617-897-8294

Web site: http://www.tolerx.com/http://www.defendagainstdiabetes.com/

Carney Has Busy Day in Area Visits Memorial Hospital, Makes Presentation in Wysox Township

By James Loewenstein, The Daily Review, Towanda, Pa.

Aug. 6–TOWANDA — U.S. Rep. Chris Carney was in Bradford County on Tuesday, where he presented a $738,000 check to help bring municipal water service to Wysox Township, and met with officials at Memorial Hospital, where he was thanked for his role in expanding Medicare coverage in the area of cardiac and pulmonary rehabilitation.

Memorial Hospital

Carney had helped pass recent legislation that expands Medicare coverage in the area of cardiac and pulmonary rehabilitation, officials at Memorial Hospital said.

Without the legislation in place, Medicare might or might not cover such rehabilitation, depending on which area of the country the patient lived in, said Lynn Dibble, vice-president for patient services at the hospital.

The passage of the legislation assures that Medicare will cover the rehabilitation, no matter which area of the country the patient lives in, she said.

Unless Medicare pays for the rehabilitation, many people cannot afford to pay for it on their own and some will forgo the rehab, said Dibble and Linda Berry, the hospital’s vice president for human resources.

Cardiac rehabilitation gives people who have had heart attacks or open heart surgery the confidence to resume physical activity, Dibble said.

The expansion of the Medicare coverage goes into effect on Jan. 1, 2010, Dibble said.

Currently at Memorial Hospital, Medicare pays for most cardiac rehabilitation services, and does not pay for some pulmonary rehabilitation, Dibble said. When the legislation goes into effect, all of those rehabilitation services will be covered by Medicare, she said.

Municipal water

The $738,000 grant, which is from the U.S. Army Corps of Engineers, will be used to help pay to bring municipal water from Towanda Borough to Wysox Township.

The Wysox Municipal Authority is planning to purchase bulk water from the Towanda Municipal Authority for its planned $7.1 million water system in Wysox Township.

The bulk water would be piped from Towanda Borough to Wysox Township, either by laying a pipe underneath the Susquehanna River, or attaching it to the Veterans Memorial Bridge, said Bob Williams, chairman of the Wysox Municipal Authority.

James Loewenstein can be reached at (570) 265-1632; or e-mail: [email protected]

—–

To see more of The Daily Review or to subscribe to the newspaper, visit http://www.thedailyreview.com.

Copyright (c) 2008, The Daily Review, Towanda, Pa.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Lessons for Today’s Battlefield Surgeon, Uncensored

By Donald G. McNeil Jr.

The pictures show shredded limbs, burned faces, profusely bleeding wounds. The subjects are mostly American GIs, but they include Iraqis and Afghans, some of them young children.

They appear in a new book, “War Surgery in Afghanistan and Iraq: A Series of Cases, 2003-2007,” quietly issued by the U.S. Army – the first guidebook of new techniques for American battlefield surgeons to be published while the wars it analyzes are still being fought.

Its 83 case descriptions from 53 battlefield doctors are clinical and bone-dry, but the gruesome photographs illustrate the grim nature of today’s wars, in which more are hurt by explosions than by bullets, and body armor leaves many alive but maimed.

And the cases detail important advances in treating blast amputations, massive bleeding, bomb concussions and other front- line trauma.

Though it is expensively produced and includes a foreword by the ABC correspondent Bob Woodruff, who was severely wounded by a roadside bomb in 2006, “War Surgery” is not easy to find. There were strenuous efforts within the army over the last year to censor the book and keep it out of civilian hands.

Paradoxically, the book is being issued as news photographers complain that they are being ejected from combat areas for depicting dead and wounded Americans.

But efforts to censor the book were overruled by successive U.S. Army surgeons general. It can be ordered from the Government Printing Office for $71; Amazon.com lists it as out of stock, but the Borden Institute, the army medical office that published it, said thousands more copies would be printed.

“I’m ashamed to say that there were folks even in the medical department who said, ‘Over my dead body will American civilians see this,'” said David Lounsbury, one of the three authors. Lounsbury, 58, an internist and retired colonel, took part in the 1991 and 2003 invasions of Iraq and was the editor of military medicine textbooks at Walter Reed Army Medical Center.

“The average Joe Surgeon, civilian or military, has never seen this stuff,” Lounsbury said. “Yeah, they’ve seen guys shot in the chest. But the kind of ferocious blast, burn and penetrating trauma that’s part of the modern IED wound is like nothing they’ve seen, even in a Manhattan emergency room,” using the initials for what the Pentagon calls an “improvised explosive device,” or roadside bomb. “It’s a shocking, heart-stopping, eye-opening kind of thing. And they need to see this on the plane before they get there, because there’s a learning curve to this.”

The pictures of wounded children include some of a 5-year-old shot in a vehicle trying to run through a checkpoint. Other pictures show wounds enfiladed with dirt, genitals severed by a roadside bomb, a rib – presumably that of a suicide bomber – driven deep into a soldier’s body, and the tail of an unexploded rocket protruding from a soldier’s hip.

There are moments that reflect the desperation in the invaded country: an Afghan in the jaw-locked rictus of tetanus after home- treating a foot blown off by a land mine. And moments that reflect the modern U.S. Army: a soldier with unexplained pelvic pain that turns out to be a life-threatening ectopic pregnancy.

The book was created to teach techniques that surgeons adopted, abandoning old habits.

For example, they no longer pump saline into a patient with massive trauma to try to get the blood pressure back up to 120. “You do that, you end up with a highly diluted, cold patient with no clotting factors, and the high pressure restarts bleeding,” Lounsbury said. Instead, they try to bring it up to just 80 or 90 with red cells and extra platelets, which encourage clotting.

Also, initial surgery even on a severely wounded patient may be brief – just enough to control hemorrhaging and prevent contamination by a torn bowel. Then the patient is returned to intensive care to warm up, raise the blood pressure and restore the electrolyte balance. The next operation is usually just enough to stabilize the patient for transport to a more sophisticated hospital, perhaps in Baghdad or Kabul, in Germany or the United States.

The book describes a surgeon who erred fatally by trying to do too much – a four-hour operation on a soldier who had lost a leg to a roadside bomb. The effort drained the forward hospital’s blood bank, and the patient died on the helicopter to the next hospital.

Also, neurosurgeons treating a blast victim now quickly remove a large section of the skull to relieve pressure, even if no shrapnel has penetrated. Such patients are sometimes able to walk and talk after a blast but then collapse and die as their brain swells. The procedure is described by the surgeon who saved Woodruff’s life that way.

Amputations have also changed. Lounsbury’s brother lost both legs and an arm in Vietnam, and in those days clean “guillotine” amputations were done as high as possible. Now surgeons try to preserve as much bone and flesh as they can, even if the stump is unsightly. Modern prosthetics are molded to it.

Doctors have also become quicker to diagnose “compartment syndrome” even in patients too sedated to feel pain; swelling in an injured muscle can cut off the blood supply, leading to gangrene and amputation. Surgeons now “fillet” the muscles to relieve the pressure, often even before it builds, since restitching healthy tissue is better than losing a limb.

And when morphine is not enough, nerve blocks – internal drips of local anesthetic, often given by a small pump held by the patient – have become common in pain control.

Ramanathan Raju, chief medical officer for New York City Health and Hospitals and a former trauma surgeon, viewed the book and said it would be “extremely useful” to civilian surgeons because of what it teaches about blast injuries and when a surgeon should stop to let a patient recover.

“The army should be very happy about this,” Raju said. “In the past, people said, ‘Oh, army surgeons are like butchers, they’re not research oriented.’ This shows how skillful they are.”

One of the book’s most powerful aspects is its juxtaposition of operating-room photographs with those of the war outside the tent. It is filled with random shots – burning vehicles, explosions, a medic carrying a child, another in a Santa Claus hat. It also has portraits of soldiers, often dazed and exhausted; one even has tears on his cheek.

Many are by David Leeson of The Dallas Morning News, who was embedded with the 3rd Infantry Division during the Iraq invasion and who won a Pulitzer Prize for his coverage.

Even more humanizing are photos of recovered patients: an Iraqi whose jaw was destroyed shown with it rebuilt, a soldier who lost half of his skull smiling at a ceremonial dinner with his wife .

Military censors suggested numerous changes, including removing photos showing burning vehicles and the faces of any American wounded. They also wanted to excise references to branches of service and how injuries occurred.

For example, according to unclassified e-mail provided by the authors, one suggested removing this description: “A helmeted soldier suffered a forehead injury during the explosion of an improvised explosive device. He was a front-seat passenger” in a Humvee. The censor suggested: “A 22-year-old male was hurt in a blast.”

Two in the chain of command who raised such objections – one civilian and one officer – said they did so only out of concern for patients’ privacy and for security reasons.

For example, they said, wound patterns might tell the enemy that helmets and Humvees were vulnerable. The authors argued it was crucial for surgeons to expect wounds behind armor and absurd to conceal that they occurred.

Censors also tried to prevent the book from getting a copyright and the international standard book number letting it be sold commercially, Lounsbury said.

Ultimately, they were overruled.

Kevin Kiley, a retired lieutenant general who was the army’s surgeon general when the book was being prepared, said some higher- ups in the military had been worried that the pictures “could be spun politically to show the horrors of war.”

“The counterargument to that, which I concurred with,” Kiley said, “was that this is a medical textbook that could save lives.”

He said it “absolutely” ought to be available to civilians, particularly to surgeons. “There was never any doubt in my mind that the army would publish this,” he said. “It was just a matter of getting around the nitwits.”

Originally published by The New York Times Media Group.

(c) 2008 International Herald Tribune. Provided by ProQuest Information and Learning. All rights Reserved.

Mylan Creates New Women’s Health Care Franchise

PITTSBURGH, Aug. 6 /PRNewswire-FirstCall/ — Mylan Inc. announced today that it has completed an agreement with Famy Care Ltd, a global, India-based manufacturing leader of women’s health care products, to develop and supply 22 oral contraceptive (OC) medicines to customers in the United States. The agreement also provides Mylan with a right of first refusal for additional oral contraceptive products and certain additional markets, including Australia and Japan, where Mylan has a significant presence. Terms of the agreement were not disclosed.

“Through our partnership with Famy Care, we have met another longstanding commitment by expanding our portfolio to create a women’s health care franchise for Mylan,” said Mylan Vice Chairman and CEO Robert J. Coury. “We anticipate filing ANDAs as early as the next few months and beginning to commercialize them in 2010.

“After working on this initiative for some time, we have found an outstanding partner in Famy Care, the world’s largest manufacturer of oral contraceptives. Famy Care is a well-established and well-respected global company, deeply committed to quality and customer satisfaction. We’re delighted to have completed this agreement with an organization considered a world leader in generic contraceptives, and we look forward to bringing these OC medicines to U.S. customers as quickly as possible.”

“We discussed aligning Famy Care with a number of highly qualified companies, but Mylan clearly became the partner-of-choice,” said Sanjeev Taparia, Famy Care’s managing director. “We based our decision on Mylan’s strong presence in the United States, expanded global commercial footprint and its high quality and customer service standards. Mylan is well-positioned to help us achieve the vast potential we see in our diverse women’s health care product portfolio.”

Currently, total U.S. OC market sales are approximately $3.3 billion, according to IMS. Of the 42 OC products available, 31 are sold generically. OCs are dispensed primarily in retail pharmacies, although certain clinic channels, such as Planned Parenthood, are important, particularly for new customers.

Based in Mumbai, India, Famy Care manufactures a wide range of reproductive health care products, including oral and emergency contraceptives, intra-uterine devices (IUDs) and tubal ligation rings. Incorporated in 1990, the company exports its products to more than 50 countries on four continents. The company has established strong manufacturing and R&D capabilities with state-of-the-art facilities throughout India.

Mylan Inc., with a presence in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry’s broadest – and highest quality — product portfolios, supported by a robust product pipeline; owns a controlling interest in the world’s second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.

This press release includes statements that constitute “forward-looking statements,” including with regard to Mylan’s agreement with Famy Care and the anticipated ANDA filings and product commercializations. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: risks inherent in product development and regulatory matters; the effect of any changes in customer and supplier relationships and customer purchasing patterns; changes in third-party relationships; the impacts of competition; changes in economic and financial conditions of the Company’s business; and uncertainties and matters beyond the control of management. These cautionary statements should be considered in connection with any subsequent written or oral forward-looking statements that may be made by the Company or by persons acting on its behalf and in conjunction with its periodic SEC filings. In addition, please refer to the cautionary statements and risk factors in the Company’s Form 10-Q for the quarter ended March 31, 2008, and in its other filings with the SEC. The Company undertakes no obligation to update statements herein for revisions or changes after the date of this release.

Mylan Inc.

CONTACT: Media, Michael Laffin, or Investors, Kris King, both of MylanInc., +1-724-514-1813

Web site: http://www.mylan.com/

Buchtel’s Class of ’73 is Special: Refurbished Auto is Donated to Nurse

By Jewell Cardwell, The Akron Beacon Journal, Ohio

Aug. 6–It’s time for high school and college reunions.

One of the bigger ones taking place this weekend is Akron’s Buchtel High School class of ’73, which boasts nearly 400 students.

Remarkably, one of the major reasons those who graduated 35 years ago give for returning is Barbara Redd Lewis, their guidance counselor.

“She is like a second mother to many of us,” reminisces Phyllis Ford of Akron, who still calls Lewis on a regular basis.

“She has always tried to keep track of our class . . . “

Lewis, who worked as a counselor at Buchtel from 1969 to 1991, acknowledged that there was “something truly special about the class of ’73. . . . I liked all of my kids. But this class was just exceptional. “

Lewis said she often runs into members of the class at grocery stores and the like.

Some she even hears from every week. “Greg Blackmon (a chemist) calls whenever there’s a bad storm and asks ‘Are you OK? Is your electricity out?” she recounts.

David Barnes, general manager at Akron’s Mud Run Golf Course, also keeps in close touch.

Lewis, who has two sons and three grandchildren of her own, said members of the Buchtel class of ’73 feel like her own. “I don’t know what it was. Just good chemistry, I guess,” was how Lewis summed up the special and ongoing bond.

Because of that, she’s never missed attending any of their reunions.

“It’s been so gratifying to see them grow and be successful,” she continued.

“Of course, we had some situations with some of the kids. But it was nothing I couldn’t handle.

“I think in those days, the kids had more respect for themselves and authority. And you had cooperation from their parents. That made a big difference. . . .

“Anyway, this was an all-around exceptional group of kids. Some have become doctors, lawyers, bank vice presidents, authors. . . . “

Lewis began her education career as an English teacher at Akron’s Ellet High School for six years. Then she spent time at Thornton Junior High School as a counselor before moving on to Buchtel.

She retired in 1991 but was lured back to part-time work for a year.

Then it was off to Hoban High School where she spent 14 years before retiring again in 2006.

Who knows what’s next for the woman Buchtel’s class of ’73 affectionally calls their second mom.

Pulling together

God bless the Coventry Soccer Youth Organization, which is reaching out in a mighty way to help one of its own.

“The CSYO has found out that one of our coaches has stage four colon cancer that has spread to her liver and stomach, She has no health insurance,” soccer parent Jenna Raines said of the 37-year-old mother of a 7-year-old and a 10-year-old.

“The family has requested that we maintain their privacy as much as possible.

“CSYO wants to help them out, so we are having a benefit event on Saturday, Aug. 9, at Logan Field (on North Turkeyfoot Road) from 10 a.m. to 4 p.m.,” Raines continued. “We are having a bake sale, rummage sale and children’s activities. We are trying to get the word out to as many people as we can. One hundred percent of the proceeds from this event will go to this family. Jerry VanDevere (of VanDevere Auto on Arlington Road) will give matching funds up to $3,000.”

A Coventry Cares Family Benefit account is open at TeleCommunity Credit Union, 2500 N. Turkeyfoot Road, Akron, Ohio 44319, to help the family.

Fixed-up wheels

Paula Apley feels incredibly blessed. And with good reason.

First and foremost that her brain tumor was successfully removed April 25.

The nurse and single mother of two — a 14-year-old son and 10-year-old daughter — was on the receiving end last weekend of yet another, albeit different, blessing.

Akron Baptist Temple, where the 44-year-old Mogadore woman has been a member for more than 30 years and works in the Kids Zone ministry, presented her with a car Saturday at its big car show.

John “Jack” Cunningham — a member of the church’s Cruise-Saders-ABT car club and a retired captain with the Akron Police Department — said the annual event drew more than 300 cars.

The highlight, according to Cunningham, was the presentation to Apley, who works two jobs at Akron Children’s Hospital and Tallmadge Christian Academy to make ends meet. She was selected for the outreach by the pastor, Ed Holland.

According to Cunningham, the car — a 1997 Mercury Sable station wagon — was totally rebuilt from the ground up by several of the car club’s members whom he described “as some of the best in the business.”

The car was primarily rebuilt with all new parts by Keith Wright of Barberton Auto Craft with about 25 or so other local businesses chipping in to help. “The undercarriage is all new. It also has new struts and brakes,” Cunningham said. It’s better than the day it rolled off the assembly line.”

“It’s dark green metallic. Absolutely beautiful and looks likes a show car now,” Cunningham said.

Helping Ronald

Collective praise for St. John Lutheran Church, 500 E. Wilbeth Road, Akron, for its special community outreach on behalf of Akron’s Ronald McDonald House — a home away from home for out-of-the-area families with children who are seriously or critically ill and patients at Akron Children’s Hospital.

The church is sponsoring an old-fashioned “Ice Cream Social” from 2 to 4 p.m. Sunday, Sept. 7, with all proceeds going to the House.

The event also will serve as a “Back to School” fun fair for adults and children of all ages with a clown and games for entertainment.

Getting there

Major bouquets to Brunswick, Wadsworth Expanded Transportations Options volunteers who transport residents to out-of-county medical appointments.

The ETO service is a coalition program involving Faith in Action Medina County Caregivers, financially supported by United Way of Medina County, and maintained by Medina County Public Transit and in partnership with Medina County Transit Consortium.

“It is so hard for our seniors and the medically fragile to keep these out-of-county appointments,” said Faith in Action director Doris Kilbane. “There’s no other service available. Their friends often can’t drive or have passed away and their families are not close or are unable to repeatedly take off work. . . . You can help them get the medical care they need by offering your time.”

For more information, please call 330-952-0342. Jewell Cardwell can be reached at 330-996-3567 or [email protected].

—–

To see more of the Akron Beacon Journal, or to subscribe to the newspaper, go to http://www.ohio.com.

Copyright (c) 2008, The Akron Beacon Journal, Ohio

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

A 24-Hour Fitness Center

By B.C. Manion, Tampa Tribune, Fla.

Aug. 6–KEYSTONE — Construction continues on Anytime Fitness — a 24-hour gym that’s expected to open in mid- to late-September.

The 4,200-square-foot center at 17765 Gunn Highway will feature top-of-the-line equipment and a sophisticated security system, said the gym’s owner, James Magliulo.

Equipment will include elliptical cross trainers, treadmills, upright bicycles and StairMasters. There also will be full lines of free weights and strengthening equipment and tanning facilities, Magliulo said.

The center also will have certified personal trainers.

One highlight will be the center’s flat-screen televisions, which will be mounted to individual pieces of cardio equipment, Magliulo said. It also will have televisions mounted to the ceiling.

The gym will be open 24 hours but will be staffed only from 9 a.m. to 8 p.m.

Members wanting to use the center after hours will have an electronic key card to let themselves in, Magliulo said. If someone quits, the club will deactivate his card.

The club’s security system includes surveillance cameras and a panic button inside that members can press if they feel threatened after hours. There also will be necklaces, equipped with a panic button, for members to wear when they are walking to their cars.

Magliulo wants the center to be a personal place where the members and staff know each other by first names.

The gym is being opened north of Van Dyke Road on Gunn Highway because it’s desperately needed there, Magliulo said.

“The closest place for anyone to work out there was 51/2 miles away, and with gas being $4 a gallon, I was embraced by the community,” he said.

Although the center received a warm reception by people who want to work out, it drew opposition from the Keystone Civic Association, which unsuccessfully challenged its bid for around-the-clock operations.

The facility will likely draw a handful of people to work out after hours, Magliulo said. It will have far less impact than a 24-hour convenience store because it’s only open to its private membership, he said.

An opening day hasn’t been set because construction is not done, Magliulo said. In the interim, he is offering a limited number of discounted memberships in a “preopening” sale.

Membership will be available on a month-to-month basis, and costs will range from $29 to $39 a month, with discounted rates offered for longer-term memberships.

By joining the gym, members will be able to work out for free at any of the Anytime Fitness franchise locations, Magliulo said.

Anytime Fitness’ Web site predicts there will be 1,000 locations by the end of this year. The majority of the centers are in the United States, but there are a few international locations. The Tampa Bay area has more than a dozen locations, and more than a dozen are expected to open soon.

ANYTIME FITNESS

— Under construction at 17765 Gunn Highway (near the northeast corner of Gunn Highway and Van Dyke Road)

— For information, call (813) 926-6777 or go to www .anytimefitness.com

Reporter B.C. Manion can be reached at (813) 865-1507 or [email protected].

—–

To see more of the Tampa Tribune or to subscribe to the newspaper, go to http://www.tampatrib.com.

Copyright (c) 2008, Tampa Tribune, Fla.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

For Young Swimmer, Water is a Way of Life

By Kate Ericsson Special to SWoCo

Swimming with the grace of a dancer and the speed of a sprinter, Khalil Fonder, a rising third-grader at W.E. Cundiff, is making waves in the swimming world locally and nationally.

Khalil has been swimming for Forest Hills Swim Club in the summer and year-round at the Gator Aquatic Center for the past four years. He holds Gator team records in 50 fly, 50 back and 100 fly, and has a national USA swimming record for 50 fly, ranking eighth in the country in the 8 and under division. He was the recipient of the Tyler Nordgren Award given by the Roanoke Valley Aquatic Association in 2006 — an award given to younger swimmers embodying enthusiasm and ability to overcome challenges.

This year Khalil is swimming in the 9-10 age group for Forest Hills, but is confident that he’ll continue to set records and place in meets. He counts his family as his source of inspiration and motivation. “I love my Mom. She does so much for me and always takes me to my sports practices.”

He follows in the footsteps of big swimmers: his two older sisters swam for Virginia Tech and Radford. His parents, Doug and Kathy Fonder, are coaches at the Gator Club, so swimming is not just recreational — it’s a way of life for the Fonders.

Khalil believes his swimming helps him outside of the pool. “It helps me run fast in baseball and gives me energy on the basketball court.” He enjoys team sports as much as swimming, but believes that swimming is the sport that taught him “to always do my best and be a good sport.”

Fellow Gator swimmer Emma Cartledge said, “Khalil is fun to have on the team. He’s very encouraging.”

Teammate Keith Myburgh agrees. “We have a lot of fun before and after practice together.”

Outside of sports he spends time with friends, keeps up with his homework, plays Webkinz and Wii video games, takes care of his Siberian husky puppy and shoots hoops on his backyard basketball court.

Despite all his interests, swimming is his passion. The only sports injury that has deterred Khalil from practicing was a minor one — to his pinky — that happened at school. “Nothing stops me from swimming,” said Khalil.

Kate Ericsson is a former classroom teacher and reading specialist who currently tutors, writes, runs and tries to keep up with her kids.|

Forest Hills Swim Club

n Located at 3360 Kenwick Trail in the Cave Spring Area. The summer swim team is part of the Roanoke Valley Aquatic Association (swimrvaa.com). Forest Hills competes in Monday night swim meets and a final city/county championship to be held July 25 and 26 at the Salem YMCA.

n Web site: foresthillsswimclub.com)

(c) 2008 Roanoke Times & World News. Provided by ProQuest Information and Learning. All rights Reserved.

Young Cancer-Sufferer Gets Singing Lessons From Top Choir

By CHRIS MALLETT

A Teenage music-lover who has been treated for cancer for nearly six years has taken singing lessons with an international gospel choir, thanks to a children’s charity.

Alex Cooper, now 16, was told he had between six and 12 months to live when he was diagnosed with a brain tumour in August 2002.

But, with the help of a trial form of chemotherapy, he was given the all-clear by doctors two years ago.

The cancer and its treatments gave him a poor short-term memory, tunnel vision, and made it difficult for him to walk far, but he never lost his passion for music.

Now, with the help of children’s charity The Joshua Foundation, he has been able to hone his skills with London Community Gospel Choir, which performed at Wayne Rooney’s wedding.

His mother, Lorraine, 47, of Linden Close, Kilburn, said the trip, which included Alex having private singing lessons with the choir’s principal, the Rev Bazil Meade, had been fantastic.

She said: “It was wonderful. They said his singing was very good. They were great with him. He knew some of the songs but the Reverend made sure he told him the lines before he sang them because of his short-term memory.

“They gave him a goody bag with music vouchers and we went for a meal – all sorted out by the foundation.”

Alex sang for the choir at his school, John Flamsteed, in Denby, and during visits to a holiday home in Scotland for adolescents with cancer. He hopes to pursue this interest when he starts a performing and creative skills course at Derby College next month.

Staff at Queen’s Medical Centre, in Nottingham, knew about his talent and gave the Joshua Foundation his details when it asked if any of the hospital’s young cancer patients would enjoy the trip to London.

Alex said he was grateful to the charity, which helps fulfil the wishes of cancer sufferers. “I really enjoyed it. I’m definitely going to keep going with my singing lessons.”

Alex was given the all-clear two years ago, to the delight of his mother and father, Paul, 48. In January 2003, after emergency surgery and radiography had failed, they were told he had only weeks to live and agreed he should receive a trial form of chemotherapy called Temolozomide.

The treatment, which is now more commonplace, was a great success.

Over three-and-a-half years, Alex’s condition gradually improved, although a second drug, Thalidomide, which prevents new cancer cells from forming, made him feel tired.

Now, Lorraine says doctors are considering whether to take him off the second drug.

She said: “We are so proud of him. He’s always taken everything in his stride and has never let us get upset.”

Alex, who still suffers some hair-loss due to the radiotherapy, may also need to have a metal plate inserted in his skull.

(c) 2008 Derby Evening Telegraph. Provided by ProQuest Information and Learning. All rights Reserved.

WI Ladies Back Moves to Legalise Brothels

By JENNA RICHARDS

Members of South Devon’s Women’s Institute branches have supported calls to legalise brothels.

The women spoke out after a Channel Four documentary showed the Hampshire County Federation of Women’s Institutes calling for prostitution to be legalised.

The licensing of brothels was the subject of its motion for debate at the autumn meeting last year of the WI’s Hampshire Federation, which has 6,000 members. The motion received almost unanimous backing. Now South Devon members have backed their Hampshire colleagues’ campaign.

Brixham WI chairman Elly Challoner said: “We’ve been talking about this for a while and most of our ladies agree with those in Hampshire.

“My personal view is that if this is the way the girls are making their living, then they should be able to get protection.

“Some of the things I saw on the programme, such as fitting rooms with panic alarms connected to the police, were excellent ideas.

“I think that the WI is made up of sensible women and it is a common sense view to protect these girls- after all they are women too.”

Patricia Wyatt, chairman of the Wellswood women’s institute in Torquay, also supported the calls to legalise prostitution. She said: “I totally agree that brothels should be legalised. It is about time a suitable organisation did something about this issue.

“I feel very sorry for the girls who feel this is the best way to earn a living. However, it is not a simple issue, there are other things that need to be addressed such as housing, education and getting a better life for these girls.”

Wendy Kealey, of the Marldon evening WI, also thinks protecting working girls is a good thing.

If brothels were legalised, they would need to be licensed. Cllr Peter Addis, chairman of the licensing committee, said: “If it saves one rape or abuse case then it could be a good thing – but it would have to be proved.”

The Channel Four documentary, shown on Sunday, followed two Hampshire WI members embark on a global mission to investigate the effects that laws elsewhere have on prostitution and searching for the perfect brothel.

They visited Amsterdam and found out what it feels like to work in a window brothel.

In Nevada, they joined the line-up in one of Nevada’s licensed sex ranches.

And in New Zealand, they experienced the luxury of an upmarket self-run prostitution co-op.

They returned to England armed with plenty of ideas and determined to bring their resolution before the WI national meeting in 2009.

(c) 2008 Herald Express (Torquay UK). Provided by ProQuest Information and Learning. All rights Reserved.

Three Dead in Forest Hills Crash Are Identified

Three people died last night when a car crashed into a utility pole in the grass median of Ardmore Boulevard in Forest Hills.

Two men and a woman were killed and a 4-year-old girl seriously injured in the 9:20 p.m. wreck near the intersection with Newport Road, Allegheny County police said.

The unnamed driver was treated at UPMC Presbyterian for minor cuts and released, said county police Lt. Bill Palmer.

The county Medical Examiner’s office identified the dead passengers as: Matthew Stojakovich, 25, who recently moved to Altoona from North Huntingdon; Jennifer Smith, 26, of Johnstown; and Samuel McCoy, 27, of Altoona.

The driver and Smith’s 4-year-old daughter were trapped in the wreckage until emergency workers rescued them.

The girl, who was trapped for about an hour, is in serious condition at Children’s Hospital of Pittsburgh with a broken leg and injured left shoulder and left arm, Palmer said.

Police accident reconstruction specialists are investigating and have not determined what caused the driver to go off the road, he said.

Originally published by The Tribune-Review.

(c) 2008 Tribune-Review/Pittsburgh Tribune-Review. Provided by ProQuest Information and Learning. All rights Reserved.

Autistic Boy Found Safe After Two Days

By LAURA McVICKER

An 11-year-old autistic Portland boy, lost for two nights in wilderness near Mount St. Helens, was found safe Monday morning.

Just after 6 a.m., Alex Irvin walked to the clearing of the Siouxon trailhead as searchers were mobilizing with dogs. He wasn’t injured, although he was hungry, said Skamania County Undersheriff Dave Cox.

“All of the sudden, here he came out of the trail,” Cox said. “We were real fortunate.”

Alex wandered away from his father Saturday afternoon on the Siouxon Trail, which is about eight miles east of the Mount St. Helens National Volcanic Monument. The two were touring waterfalls when the 11-year-old ran ahead, Cox said.

His father mounted his own search on area trails before calling sheriff’s deputies at about 9 p.m. Deputies began a ground search that night.

On Sunday, the search grew to 70 people and included aircraft from the Washington Air National Guard and Washington State Patrol. Rescuers from Skamania, Cowlitz, Clark, Pierce and Yakima counties also helped with the effort. Searchers scoured the steep and heavily brushed terrain on ATV vehicles, mounted on horseback and on foot.

Rescuers were especially concerned because Alex has autism and doesn’t typically respond when he hears his name. But the boy, who was wearing only shorts and a sweatshirt and didn’t have food or water, was described as intrepid.

“This young man was a pretty hearty boy for being out in the woods for two nights,” Cox said.

Originally published by LAURA McVICKER Columbian staff writer.

(c) 2008 Columbian. Provided by ProQuest Information and Learning. All rights Reserved.

Global Pulmonology Thought Leaders Provide Insight Into COPD and Asthma Drug Development Pipeline

SCOTTSDALE, Ariz., Aug. 5 /PRNewswire/ — MedPredict, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for pharma and biotech companies with a stake in the market for asthma and chronic obstructive pulmonary disease (COPD) therapies.

In this report, entitled “MedPredict Thought Leader Insight & Analysis: Respiratory Disorders,” a panel of world-class pulmonologists outlines the unmet needs in the treatment of asthma and COPD and then drills down into subtle differences between combination therapies, translating their attributes into the benefits each delivers. These discussions encompass once- and twice daily LABAs (long-acting beta agonists), steroids, leukotriene inhibitors, anticholinergics, FLAP, CXCR2 and other mechanisms. The panel also considers each of these approaches in the context of prn vs. maintenance dosing.

“There is a lot of commercial development activity aimed at identifying biologicals that have disease-modifying activity, both in asthma and COPD,” said Jeff Berk, the report’s author. “Our panel sorts through the biologicals in the pipeline, including monoclonals targeting IL-5, IL-9 and IL-13/IL-4, and picks their favorites.” Also addressed in this report:

   -- What are the key unmet needs in asthma and in COPD, and which      compounds/combinations are best poised to fill the need gaps?   -- Which of the new biologicals in development show the most promise, and      why?  Will these be likely to replace current standard of care?   -- Will developers be able to show disease-modification benefits in COPD?   -- How will the increased mortality seen in the SMART trial affect usage      of LABAs in asthma?    

Companies/Partnerships discussed include: Aerovance (Bayer-Schering), Altair Therapeutics/Isis, Amgen/Takeda Bio, Boehringer Ingelheim, Ception, Chiesi, Cornerstone BioPharma/Critical Therapeutics/Dey, Forest, GlaxoSmithKline, GSK/Theravance, GSK/Amira, Merck, Merck/Schering- Plough, Novartis, Novartis/Genentech, Novartis/Schering-Plough/SkyePharma, Nycomed/Sepracor, Schering-Plough/ALK-Abello, Sepracor, SkyePharma/Kos/Abbott, Stallergenes/Paladin, Wyeth.

   This report can be purchased by contacting MedPredict.    About MedPredict  

MedPredict (http://www.medpredict.com/) maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.

MedPredict

CONTACT: Elizabeth Mathews of MedPredict, +1-513-271-1924,[email protected]

Web site: http://www.medpredict.com/

Caring for Those With Cancer ; As the Charity Marie Curie Cancer Care Celebrates Its 60th Birthday, Hannah Davies Reports on the People Whose Lives It Has Touched.

By Hannah Davies

CARED FOR Doreen Butcher, who died from lung cancer aged 72.; THANKS Mandy Butcher is grateful for the help her mother received;

SURPRISED Eleanor White was initially reluctant to go to the Marie Curie Centre for support.;

PEACEFUL The Marie Curie Hospice in Newcastle’s West End. Below, when the building work first started.;

ROYAL The Duchess of Gloucester, who visited the hospice on May 8, 1997.

HAVING a close relative with incurable cancer is one of the worst experiences you can have,” says Mandy Butcher.

“But Marie Curie Cancer Care made everything easier, and much, much, better for my mum.”

Mandy is just one of the millions of people across the UK who are touched by cancer. And, like many of those millions, Mandy and her mum Doreen had their lives improved by the charity Marie Curie Cancer Care.

The Marie Curie Hospice in Newcastle’s West End is the biggest hospice in the region and each year gives care and support to hundreds of people with cancer and their families and friends.

Mandy can’t praise Newcastle’s Marie Curie Hospice enough. The sales assistant, of Forest Hall, North Tyneside, knows her mum Doreen’s final months were made much happier by the care she received.

She said: “They really do their best in hospital but it is a very different thing. There are set visiting hours and you can never escape the fact it is a hospital. Marie Curie’s hospice was so different and so much better.”

Doreen was diagnosed with terminal lung cancer in November last year.

“For a few months she had been feeling ill,” Mandy recalls. “She’d had a pain in her shoulder and then found a lump. The doctor sent her to get it checked out and that’s when they discovered she had lung cancer.”

When they realised the extent of Doreen’s cancer Mandy and her family pushed to get her into the Marie Curie Hospice.

Mandy adds: “We knew from other relatives how good the hospice was meant to be.

“Mum spent Christmas Eve in the RVI and we pushed to move her into Marie Curie for three weeks after she got diagnosed. We were delighted when she got a place.”

Doreen was cared for in the hospice from December until March when she died at the age of 72.

Mandy, who is one of six siblings, recalls: “The whole time we were there the staff were fantastic not only for my mum but for the whole family.

“They were so supportive and caring.”

Mandy says the hospice was a less intimidating place than hospital for her two children Sam, 16, and Ellie, 11, to visit.

“Although they were too upset in the later stage it was a comforting atmosphere,” she says.

To say thanks to the centre, Mandy’s partner Paul, a pub manager, has raised over pounds 3,000 with the help of customers in his pubs and friends and relatives.

The family also asked people to donate to the charity instead of buying flowers at Doreen’s funeral.

Mandy states: “I know if my mum hadn’t had the hospice and the support of all of the staff there her final days would have been much worse than they were.

“I can’t praise the people at Marie Curie enough for everything they did to help all the family, and especially my mum.”

Marie Curie Hospice Staff nurse Alison Fisher, 43, of Seaton Delaval, has been working in the Newcastle hospice for 19 years.

She said: “I thought there wasn’t that much which could be done for people who were seriously ill until I took a course a few months before I came to the Marie Curie Hospice.

“I was astounded at the amount of difference good care could make to a person, how much it could impact their lives.”

Alison was further impressed by the difference care could make by a patient at her previous job at North Tyneside General Hospital in North Shields.

“This woman had breast cancer and came in in terrible pain. By the time she left she walked out, her pain completely under control.”

This began Alison’s interest in looking after patients with serious illnesses. A few weeks later she had applied for a job at the Marie Curie Hospice.

In her 19 years Alison has seen many people come and go. She adds: “People leave as well to return to their own homes, it’s not a place people just come to end their lives.

“There is a lot of fear over the word hospice, usually by people who have never come in. When people visit they are often surprised by the whole atmosphere of the place.”

Each year the Marie Curie Hospice in Newcastle cares for over 400 patients in their inpatient ward, has over 1,000 day therapy attendances and over 700 outpatient appointments.

Over the years that adds up to a huge number of people, and their relatives, who have been helped by the charity.

Alison says her work gives her a huge sense of satisfaction. She adds: “There is obviously a lot of sadness in the work I do, but overall it is very uplifting. You are there for people at a very difficult time in their lives and being able to make a difference is fantastic.”

Eleanor White, 76, has been going to the Marie Curie Hospice as a day visitor for around nine years.

The grandmother, of South Denton, Newcastle, was diagnosed with a rare type of cancer – granulosa cells tumours – aged 61, shortly after she had retired as an estate agent.

“It took doctors a while to diagnose what it was because it is so rare,” Eleanor explains.

She has had 15 operations as the only way to treat the cancer at the moment is by removing tumours when they appear.

Initially, despite the urging of medical staff and her family Eleanor was reluctant to go to the Marie Curie Centre for support.

“My sister and the Macmillan nurse told me I should start going to the centre,” she explains.

“I said ‘well I’m not ready for that’.

But all the medical staff if you asked any of them they said the same thing.

“My sister said ‘you haven’t even been!'”

Eventually Eleanor, a widow whose son Steven, 52, daughter-in- law Irene and granddaughter Crystal, 23, all live close by, gave in and she was surprised at how much she loved the centre.

“From the very first moment I went into the centre I was just bowled over,” she says. “As soon as I walked through the door I couldn’t believe it.

“Something came over me, this safe feeling of community. It has got a wonderful calming atmosphere.

From the start they were marvellous.”

Eleanor says the care she receives at the centre is fantastic. One of her doctors was walking along the corridor with her and was suspicious of a cough Eleanor had.

“I insisted it was just a cold but she made sure I was scanned. And I was diagnosed with a pulmonary embolism. That’s the level of attention and care I’ve received from the centre.”

Eleanor goes to the centre every Tuesday. In over a decade of living with cancer she has found it to be an irreplaceable source of support.

“Most of the time we chat about what we have been up to, but when you’re feeling down its really good to be able to speak to people and say openly, ‘I’m having a bad day’.

“You always try and protect your family from feelings like that so its good to have a place where you can let it all out.”

Eleanor says that without the Marie Curie Centre she would have found life much more difficult.

“What I really want to get across is it’s not just me who feels this way about the help and support we’ve received from Marie Curie Cancer Care – it is all of us.”

If you would like to make a contribution to Marie Curie Newcastle contact (0191) 219-1241. For general information call (0191) 219- 1000.

FACT FILE

MARIE Curie Cancer Care was established in 1948, the same year as the NHS.

Marie Curie Cancer Care is one of the UK’s largest charities.

It employs more than 2,700 nurses, doctors and other healthcare professionals.

The charity looks after around 27,000 terminally ill patients in the community and in hospices a year, along with support for their families. It mainly cares for people with cancer but also cares for people with other life limiting illnesses.

The charity is widely known for its network of Marie Curie nurses working in the community to provide end-of-life care for patients in their own homes.

Marie Curie has 10 hospices across England, Scotland, Wales and Northern Ireland, and two centres for palliative care research.

It also runs the worldrenowned Marie Curie Research Institute, which investigates the causes and treatments of cancer.

Marie Curie services are always free of charge to patients and their families which means the charity needs to raise more than pounds 115m a year.

The Newcastle centre offers physiotherapy, occupational and associated therapies along with social and psychological support to patients, families and carers, including bereavement and family support work.

It costs pounds 2.8m per year to run the Marie Curie Hospice in Newcastle (this excludes corporate costs such as HR).

Around half comes from local Primary Care Trusts and the NHS, the rest is raised via fundraising efforts with around pounds 1/2 m annual shortfall drawn from Head Office in London.

Marie Curie Cancer Care aims to significantly increase the charitable funding of the region’s hospice It is sustained and supported by the people of the North East.

A NIGHT WITH JASON DONOVAN

AN evening with Jason Donovan is being held in support of Marie Curie Cancer Care on Saturday, October 4.

The event at Marriott Gosforth Park Hotel includes the chance to get up close to the legend of the 80s & 90s pop scene. Jason will be performing some of his classic hits after a three course meal.

Platinum Tickets cost pounds 99 per person, and include a meet and greet photo session with Jason, gold tickets are pounds 79 per person, tables of 10 & 12 are available.

To book tickets or tables call (0191) 268-6546, 07791518890 or email rachelle [email protected]

(c) 2008 The Journal – Newcastle-upon-Tyne. Provided by ProQuest Information and Learning. All rights Reserved.

Drive’s Organizers Hope to Hear 64,000 K-Chings Against Cancer

By Chris Sholly, Lebanon Daily News, Pa.

Aug. 5–A quarter in today’s economy won’t buy much. But 64,000 quarters — that’s about $16,000 — can buy a lot.

That’s this year’s goal for the WLBR/WQIC Conquer Cancer with a Quarter campaign, which is expected to top that goal. Proceeds from the campaign benefit the Lebanon Unit of the American Cancer Society.

The Lebanon radio stations kicked off their 26th annual edition of the campaign at the Lebanon Valley Mall yesterday.

Carol Checket, volunteer coordinator for the campaign, said the campaign raised $20,318 last year, and $24,000 in 2006 — it’s best year to date.

“A lot of individuals and families have been touched by cancer,” Checket said. Checket, too, has had personal experience with the disease. Her daughter, Kristen, died of cancer in 1994.

The first campaign — the idea of Ed Burris, retired general manager of the station — was launched in 1982, and raised $1,400. Since then, the campaign has raised a total of $326,000.

Greg Lyons, WLBR’s program director and morning-show host, said both the AM station and its sister, WQIC FM, are broadcasting live from the mall throughout the week.

If you would like to contribute, there are two scales with boxes at the mall in which you can drop your quarters, Lyons said.

“The kids like to come in and see the scales move,” Lyons said.

People often drop quarters they have in their pockets into the boxes, he said. But they also bring their quarters in paper bags and boxes, he added.

This year’s event will feature speakers who will cover topics ranging from cancer research to nutrition and diet to cancer protocols. The speakers will join Laura LaBeau on her show from 9 to 11 a.m. each day at the mall.

Sandra Parker Hall, extension educator of family and consumer sciences at Penn State Cooperative Extension in Lebanon County, was to talk about nutrition and exercise today. The schedule for the rest of the week: Dr. Ruben Perez of Good Samaritan Hospital’s oncology group, tomorrow; Chandra Belani of the Penn State Cancer Institute, who will discuss cancer protocols, Thursday; and Dr. John Patrick Welch, a local family physician who will talk about his initial contact with patients after they have been diagnosed with the disease, Friday. Yesterday, Dr. Michael Verderame, associate dean of Penn State’s College of Medicine at Hershey Medical Center, talked about cancer.

Checket said there also will be outreach and educational programs on WQIC, with topics such as how to look and feel better, and smoking-cessation programs. Mike Ebersole will host the show from 10 a.m. to 2 p.m. on WQIC, and Carson Shuey will host it from 2 to 7 p.m.

Nine businesses are co-sponsoring the campaign this year.

—–

To see more of the Lebanon Daily News or to subscribe to the newspaper, go to http://www.ldnews.com/.

Copyright (c) 2008, Lebanon Daily News, Pa.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Caregivers at O’Connor Woods Nursing Home Vote to Keep Union and Raise Standards for Care

STOCKTON, Calif., Aug. 5 /PRNewswire-USNewswire/ — Caregivers at O’Connor Woods nursing home and assisted living facility will stay united in SEIU United Healthcare Workers-West, after a decisive vote on Friday by more than 210 LVNs, CNAs, activity aids and dietary and housekeeping workers. The victory comes despite a concerted anti-union effort by O’Connor Woods management.

The vote ensures that caregivers will have a formal say in decisions that affect patient care. “We won because we stayed focused on our commitment to each other and to improving care for our residents,” said Deborah Armenta, a 5-year employee at O’Connor Woods.

Healthcare workers hope to negotiate with O’Connor Woods to create safe-staffing committees to advocate for better patient care. Workers have already won safe-staffing committees at other Catholic-run facilities, including St. Joseph Medical Center in Stockton, Catholic Healthcare West in Bakersfield, and Doctors Medical Center in Modesto. Said Shannon McPherson, part of the organizing effort at the facility, “Now it’s time for management to work together with us to make O’Connor Woods a better place for seniors and a facility our community can be proud of.”

With more than 150,000 members, SEIU United Healthcare Workers-West is the fastest-growing healthcare union in the United States. We represent healthcare workers in all job classifications and all healthcare settings, including hospitals, homecare, nursing homes and clinics. Our mission is to achieve high-quality healthcare for all.

CONTACT: Jonathan Asmerom, Email [email protected], 510.387.2934 Cell

SEIU United Healthcare Workers-West

CONTACT: Jonathan Asmerom of SEIU United Healthcare Workers-West, Cell:+1-510.387.2934, [email protected]

Web Site: http://www.seiu-uhw.org/

Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A

BRIDGEWATER, N.J., Aug. 5 /PRNewswire/ — Ortho Biotech is announcing that it is voluntarily recalling one manufacturing lot (P114942A) of PROCRIT(R) (Epoetin alfa) after having identified cracks in the necks of a small number of vials upon post-manufacturing inspection. No other lot of this product is affected by this recall. Approximately 44,292 vials of lot P114942A in the following packaging configurations were distributed between April 15, 2008 and July 17, 2008.

        NDC          Description                     Lot       Expiration                                                    Number       Date   59676-312-00   Individual multi-dose vials                  of PROCRIT(R) (Epoetin alfa)     P114942A       12/10                  10,000 U/2mL   59676-312-04   Cartons containing 4                  multi-dose vials of PROCRIT(R)   P114942A       12/10                  (Epoetin alfa) 10,000 U/2mL    

Vials exhibiting even slight cracks may not maintain their sterile condition and should not be used for subcutaneous or intravenous injection.

To ensure patient safety, Ortho Biotech is voluntarily recalling PROCRIT vials from this manufacturing lot only. Ortho Biotech is notifying the authorized distributors, prescribing physicians and patients of this recall. The recall is being conducted in cooperation with the U.S. Food and Drug Administration.

PROCRIT from manufacturing lots other than the above, shipped from an authorized distributor is not being recalled.

PROCRIT vials from the above recalled lot should be promptly returned by contacting the returned goods service provider, at (800) 668-4391.

Healthcare providers and patients with questions about this recall notice can contact the Ortho Biotech Medical Information Department at (888) 227-5624, Monday through Friday, 8:30 am to 5:00 pm EDT.

The amount of PROCRIT being withdrawn represents a very small proportion of the total product within the distribution channel; therefore the company does not anticipate a disruption in product availability for patients.

About Ortho Biotech, L.P.

Ortho Biotech Products, L.P. is a leading biopharmaceutical company devoted to helping improve the lives of patients with cancer and with anemia due to multiple causes, including chronic kidney disease. Since it was founded in 1990, Ortho Biotech and its worldwide affiliates have earned a global reputation for researching, manufacturing and marketing innovative products that enhance patients’ health. Located in Bridgewater, N.J., Ortho Biotech is an established market leader in Epoetin alfa therapy for anemia management. The company also markets treatments for recurrent ovarian cancer, rejection of transplanted organs and other serious illnesses. For more information, visit http://www.orthobiotech.com/.

Ortho Biotech, L.P.

CONTACT: Kassy McGourty, cell +1-908-377-5873, [email protected],for Ortho Biotech, L.P.

Web site: http://www.orthobiotech.com/

Curacyte Sells Its Subsidiary Curacyte Discovery GmbH to The Medicines Company

Curacyte AG today announced that it has sold its wholly owned subsidiary, Curacyte Discovery GmbH based in Leipzig (Germany) to The Medicines Company (NASDAQ: MDCO). Curacyte Discovery is engaged in the development of synthetic serine protease inhibitors in the area of hemostasis and anti-coagulation. Its rationally-designed lead development candidate, CU-2010, is being developed for preventing surgical blood loss. It is scheduled to enter Phase I clinical development by the end of 2008.

Curacyte AG and its wholly owned subsidiary Apex Bioscience (Chapel Hill, NC, USA) will continue to develop its lead product hemoximer (Pyridoxalated Hemoglobin Polyoxyethylene, PHP) in a Phase III pivotal trial in patients suffering from catecholamine-resistant distributive shock.

Curacyte received a payment of EUR 14.5 million upon signing of the agreement. In addition, Curacyte will be eligible to receive a payment of EUR 10.5 million when The Medicines Company progresses CU-2010 into Phase II clinical development as well as future commercial milestone and royalty payments.

“We are very proud of The Medicines Company acquiring Curacyte Discovery and thereby acknowledging what we have built and developed over the past years. At The Medicines Company, Curacyte Discovery will be embedded in and complement a fully integrated value chain with direct access to the critical care markets.” said Dr. Helmut Giersiefen, CEO of Curacyte AG. He further stated that “the transaction will help the parent company, Curacyte AG, to focus on fully developing its key product, hemoximer, in a pivotal Phase III study in distributive shock.”

Curacyte is currently initiating the Phase III study which will be conducted in patients suffering from distributive shock and not responding to standard therapy in form of catecholamines. Worldwide, more than 2 million patients suffer from distributive shock per annum. Recent clinical data suggests that more than 50% of these patients do not respond to catecholamines, e.g., norepinephrine, the only therapy to treat shock. Non-responders have only a 20% chance to survive this serious condition with no alternative treatment option. The Phase III study is expected to last for two years and is planned to be conducted in the Europe and the United States.

About Curacyte

Curacyte Discovery GmbH, is a wholly-owned subsidiary of Curacyte AG. Curacyte AG is an advanced biopharmaceutical company dedicated to the development of new therapeutics for acute and critical care conditions.

Curacyte’s lead product is hemoximer (Pyridoxalated Hemoglobin Polyoxyethylene, PHP). Hemoximer has been developed as a scavenger of nitric oxide, the causative agent responsible for vasodilation and hypotension in shock. The ability to scavenge and metabolize NO is one of the important physiological functions of natural hemoglobin. Hemoximer has been demonstrated to reverse the vasodilation and resolve the hypotension associated with distributive shock. Hemoximer has completed Phase II clinical development in its primary indication, distributive shock, and is now entering a Phase III study in catecholamine-resistant distributive shock. Apart from distributive shock, hemoximer is also being studied as an adjunct to high-dose interleukin 2 (IL-2) cancer therapy for patients with metastatic melanoma and renal cell carcinoma. Shock is a frequent dose-limiting side effect of high-dose IL-2 therapy. Hemoximer is the proposed International Non-Proprietary Name (INN) for PHP. The Company’s website is www.curacyte.eu.

About The Medicines Company

The Medicines Company (NASDAQ: MDCO) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax(R) (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, as well as Cleviprex(TM) (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Company also has one product, cangrelor, in late-stage development. The Company’s website is www.themedicinescompany.com.

Oculus Innovative Sciences Reports 59% Increase in First Quarter Product Revenue

Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) today announced financial and operating results for the first quarter of fiscal year 2009, ended June 30, 2008.

Total revenue for the quarter was $1.2 million, an increase of 39% over $866,000 in the first quarter of fiscal 2008. Product revenue was $1.0 million, up 59% from $632,000 in the prior year, primarily due to higher sales in Mexico, Europe and India. Service revenue declined 13% to $204,000 as a result of the company’s focus on increasing product sales worldwide.

“We are moving aggressively to capitalize upon our existing regulatory approvals, human clinical data and partnerships to increase revenue and build a strong financial base. We believe product revenue will continue to increase as we advance our commercialization efforts in China, Europe, India, Mexico and the United States,” said Hoji Alimi, president and founder of Oculus. “In the quarter we focused on executing our commercial strategy while making progress on multiple fronts. On the drug development side we await the end-of-Phase II meeting with the FDA, which is scheduled for late August. Following that meeting we will determine the next steps of our clinical program. We believe that the U.S. drug development program and related clinical trials will enhance the value of the Microcyn Technology to partners and to the market.”

The gross margin on product revenue for the first quarter of fiscal 2009 was 57%, up from 41% in the comparable quarter a year ago primarily due to higher sales volume. Operating expenses of $5.6 million were essentially unchanged from the prior year. The loss from operations in the quarter declined to $5.1 million from a loss from operations of $5.4 million in the first quarter of fiscal 2008. The net loss for the fiscal 2009 first quarter was $5.2 million, or $0.33 per share, compared with a net loss for the fiscal 2008 first quarter of $5.0 million, or $0.42 per share. Non-cash stock-compensation expense for the quarter was $456,000, compared with $210,000 in the same quarter last year.

As of June 30, 2008, Oculus had unrestricted cash and cash equivalents of $11.5 million, compared with $18.8 million as of March 31, 2008.

Commercial Progress

Oculus is pursuing revenue growth along three fronts: 1) addition of new partners and new territories, 2) commercialization of new products in existing and new markets, such as the Microcyn gel and the Microcyn Delivery Device (MDD), and 3) further identification and approval of additional treatment indications and applications for current products. To highlight the potential of this third growth category, the company has seen positive clinical evidence from results of physician studies for the use of Microcyn Technology in abdominal lavage, oral rinse and post-caesarean sections, among others.

The company has made significant recent progress in each of these areas, including:

— Making initial shipment of Microcyn products to China in July under Oculus’ agreement with China Bao Tai (CBT). CBT has licensed two major Chinese distributors — Sinopharm (hospitals) and Lianhua Supermarkets (retail pharmacies) – to position Microcyn for the large Chinese market. Earlier this year, Microcyn was approved by the Chinese State Food and Drug Administration for the treatment of various acute and chronic wounds, including ulcers, cuts, contusions and burns.

— Signing a development agreement with Bayer Australia Animal Health and with Bayer (Sichuan) Animal Health Co. Ltd. for Microcyn Technology in animal markets for Australia and China, respectively. Each Bayer unit will be responsible for product development and regulatory approvals in its respective territory, and each holds a right of first negotiation to a commercial agreement with Oculus for distribution of the approved product in its respective territory.

— Completing development work on a hydrogel formulation of Microcyn that is designed to address a broad spectrum of applications, including treatment of skin disorders and burns in wound care, and as an anti-fungal in podiatry.

— Filing for patent protection for the development-stage MDD wound care device. This device is intended to accelerate healing by delivering a Microcyn-based solution to the wound site and transporting organic load from the site via a vacuum process. The MDD is designed to monitor the wound site and deliver additional Microcyn solution when required, and eliminate the need for frequent dressing changes at the site, thereby allowing for healthy fibroblast growth and prevention of infections. In addition, the MDD is designed for use in both out-patient and in-patient settings.

— Finalizing development of a proprietary formulation of Microcyn with antimicrobial claims that we believe will allow us to market in the United States in the over-the-counter oral care market without the need for further approval by the FDA. The company is seeking to align itself with an established partner to commercialize this product candidate.

— Presenting a peer-reviewed abstract relating to the efficacy of Microcyn Technology for the treatment of atopic dermatitis at the Third Congress of the World Union of Wound Healing Societies in Toronto in June 2008.

“We have made excellent progress in recent quarters, and over the life of our company we have demonstrated the unique and powerful safety, efficacy and healing properties of Microcyn through use on more than 750,000 patients in 25 clinical trials and in a rigorous Phase II clinical study in the United States,” said Alimi. “We believe that advancing our commercial program has provided Oculus with a strong network of business partners and distributors around the globe, proven commercial-scale manufacturing capability in Europe and Mexico, and an established brand name with healthcare professionals. We are well positioned to achieve further progress with new partners, products and therapeutic applications.”

Outlook

Oculus expects to continue to achieve strong growth in sales of Microcyn-based products over the coming years through international partnerships, although quarterly rates of growth are difficult to forecast accurately as some marketing approvals and distribution agreements are recent, and timing of sales and deliveries are variable during introductory stages.

The company is leveraging current 510(k) approvals, results of a Phase II clinical trial and brand recognition among medical practitioners to begin growing sales in the United States, and is seeking an expanded label claim that the company expects to further increase domestic sales.

“With our current products and partnerships we expect to see continued strong growth this fiscal year in Mexico, Europe and India, along with a nominal revenue contribution from China. We expect continued strong revenue growth on a year to year basis, resulting from new partners, new territories, new products and new applications in conjunction with our established sales, distribution and manufacturing network,” said Alimi.

Conference Call

Oculus management will hold a conference call today to discuss first quarter results and to answer questions, beginning at 4:30 p.m. Eastern time. Individuals interested in participating in the call may do so by dialing (800) 232-9476 for domestic callers or (706) 679-2532 for international callers. Those interested in listening to the conference call live via the Internet may do so at http://ir.oculusis.com/events.cfm Please log on approximately 30 minutes prior to the presentation in order to register and download the appropriate software.

A telephone replay will be available for 48 hours following the conclusion of the call by dialing (800) 642-1687 for domestic callers, or (706) 645-9291 for international callers, and entering reservation code 57954211. A webcast replay will be available on the site at http://ir.oculusis.com/events.cfm for one year following the call.

About Oculus

Oculus Innovative Sciences develops, manufactures and markets a family of products based upon the Microcyn(R) Technology platform, which is intended to help prevent and treat infections in chronic and acute wounds. The Microcyn Technology platform features a biocompatible, shelf-stable solution containing active oxychlorine compounds that is currently commercialized primarily in Europe, India and Mexico for the treatment of infected wounds. The solutions derived from this platform have demonstrated, in a variety of research and investigational studies, the ability to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria (including MRSA and VRE), viruses, fungi and spores. A recent Phase II clinical trial of Microcyn Technology conducted in the U.S. met its primary endpoints of safety and efficacy for the treatment of mildly infected diabetic foot ulcers.

Oculus also develops, manufactures and markets a number of devices and products under 510(k) regulatory approvals to professionals and consumers. The company’s headquarters are in Petaluma, California, with operations in Europe, Latin America and Japan. More information can be found at www.oculusis.com.

Forward Looking Statements

Except for historical information herein, some matters set forth in this press release are forward-looking within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including statements about Microcyn’s safety, efficacy and wound healing capabilities, and the ability of Microcyn to become a new type of drug for comprehensive treatment of diverse inflammatory conditions. These forward-looking statements are identified by the use of words such as “believe,””pursue,””intend,””design,””looking,””leverage,””seeking” and “expects,” among others, and include statements about our belief that product revenue will continue to increase generally or at any specific rate, our belief that we will advance our commercialization efforts, our belief that the U.S. drug development program and trials will enhance the value of Microcyn Technology, our ability to successfully pursue revenue growth with new partners and in new territories, our ability to develop and commercialize new products (including the MDD), our ability to identify and obtain approval for treatment indications and applications, the ability of our product and product candidates to address indications as designed for or as intended, our ability to leverage our current regulatory approvals, expand label claims and commercialize our products and product candidates over-the-counter or without the need for further regulatory approval, the ability of our products and products candidates to result in cost savings, our ability to obtain patent protection for new products and product candidates, and our ability to identify or align ourselves with new partners. Forward-looking statements in this press release are subject to certain risks and uncertainties inherent in the Company’s business that could cause actual results to vary, including risks inherent in the development and commercialization of potential products, the risk that regulatory clinical and guideline developments may change, the risk that scientific data may not be sufficient to meet regulatory standards or receipt of required regulatory clearances or approvals, the risk that clinical results may not be replicated in actual patient settings, the risk that protection offered by our patents and patent applications may be challenged, invalidated or circumvented by our competitors, the risk that present treatment trends will continue and that the available market for our products will not be as large as expected, the risk that our products will not be able to penetrate one or more targeted markets, the risk that our work force is inadequate to implement our business plan, the risk that we are unable to identify or align ourselves with strategic partners, the risk that revenues will not be sufficient to fund further development and clinical studies, the Company’s future capital needs, and its ability to obtain additional funding and other risks detailed from time to time in the Company’s filings with the Securities and Exchange Commission including the annual report on Form 10-K for the year ended March 31, 2008. Oculus Innovative Sciences disclaims any obligation to update these forward-looking statements.

Oculus, Microcyn and Dermacyn are trademarks or registered trademarks of Oculus Innovative Sciences, Inc. All other trademarks and service marks are the property of their respective owners.

 Oculus Innovative Sciences, Inc. Condensed Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited)   For the Three Months Ended June 30, -------------------- 2008     2007 REVENUE Product                                           $    1,007  $   632 Service                                                  204      234 ----------- -------- Total revenues                                         1,211      866 ----------- -------- COST OF REVENUES Product                                                  438      376 Service                                                  198      241 ----------- -------- Total cost of revenues                                   636      617 ----------- -------- Gross profit                                             575      249 ----------- -------- OPERATING EXPENSES Research and development                               2,321    2,207 Selling, general and administrative                    3,328    3,458 ----------- -------- Total operating expenses                               5,649    5,665 ----------- -------- Loss from operations                                  (5,074)  (5,416) Interest expense                                        (162)    (339) Interest income                                           76      206 Other income (expense), net                              (39)     531 ----------- -------- Net loss                                          $   (5,199) $(5,018) =========== ======== Net loss per common share: basic and diluted      $    (0.33) $ (0.42) =========== ======== Weighted-average number of shares used in per common share calculations: Basic and diluted         15,924   11,844 =========== ======== 

 OCULUS INNOVATIVE SCIENCES, INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (In thousands, except share and per share amounts) (Unaudited)  June 30, March 31, 2008      2008 -------------------  ASSETS Current assets: Cash and cash equivalents                          $ 11,455  $ 18,823 Accounts receivable, net                                856       770 Inventory                                               280       259 Prepaid expenses and other current assets             1,029     1,098 ------------------- Total current assets                                 13,620    20,950 Property and equipment, net                           2,243     2,303 Other assets                                            302       359 ------------------- Total assets                                       $ 16,165  $ 23,612 =================== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable                                   $  1,792  $  2,977 Accrued expenses and other current liabilities        1,379     2,460 Current portion of long-term debt and capital lease obligations                                    1,607     2,013 ------------------- Total current liabilities                             4,778     7,450 Deferred revenue                                        499       523 Long-term debt and capital lease obligations, less current portion                                        149       211 ------------------- Total liabilities                                     5,426     8,184 ------------------- Commitments and Contingencies Stockholders' Equity: Common stock, $0.0001 par value; 100,000,000 shares authorized, 15,923,708 and 15,903,613 shares issued and outstanding at June 30, 2008 (unaudited) and March 31, 2008, respectively.            2         2 Additional paid-in capital                          109,519   109,027 Accumulated other comprehensive loss                 (2,757)   (2,775) Accumulated deficit                                 (96,025)  (90,826) ------------------- Total stockholders' equity                           10,739    15,428 ------------------- Total liabilities and stockholders' equity         $ 16,165  $ 23,612 =================== 

Bad Management Causing More Stress and Absenteeism

Bureaucratic, reactive and authoritarian management styles are increasingly common in the UK, according to the Chartered Management Institute, while negative management styles are causing more stress and absenteeism in the work place.

Employers in the West Midlands recorded the highest average level of employee absence in the UK of 9.5 days a year in the CIPD’s 2008 Absence Management Survey, with stress identi8ed as one of the main causes of short-term absence.

Executive PAs often have to be the experts at managing stressful situations as many work very closely with senior management and have to meet the daily demands of everyone from middle managers to board level operators.

They regularly grapple with the need to multi-task, prioritise and organise a fast moving and dynamic environment with an ever- increasing workload, and have recognised the need to micro-manage their work environment, as well as their boss, to avoid stress.

Renee Lamb, an executive PA at Emprima, placed by Tirebuck Career Solutions who are sponsoring the PA of the Year Awards, offered some top tips on how to manage the pressure of work and create a good working relationship with your boss.

“Effective management is all about facilitating two-way communication and developing mutual respect. I have realised the need to be pro-active and probe my boss for information on a daily basis to find out what his plans are,” she said.

“In a fast-moving environment your boss can’t remember to tell you everything that is going on so I need to ensure this happens by asking pertinent questions at the right time.

“If I arrange a meeting I always try to anticipate the outcome so I can plan my future workload in advance. This means I am as prepared as I could possibly be so that, if a surprise pops up, I am better equipped to deal with it.

“When work mounts up it is essential to maintain a ‘can do’ attitude and do everything you can to get the job done, even if this means working some extra hours.

“Clients often like to surprise you but if you simply can’t handle the extra work, which often comes in at short notice, it may be time to come to some arrangement with your boss about key priorities.

“I certainly don’t go to my boss with every situation and will have a guess at how to tackle some things and take them as far as I can because this is really appreciated. The key is knowing your limitations and 8nding out how your boss likes to work.

“I am reassured that many people are tackling problem issues by picking up the phone, rather than dealing with them on email, to avoid mis-communication and con7ict, no matter what response they might get. There is no better way to reduce stress and improve understanding at work than a constructive conversation.”

For more information email Tirebuck Career Solutions which can offer more advice on [email protected] or telephone 01564 77 66 69.

(c) 2008 Birmingham Post; Birmingham (UK). Provided by ProQuest Information and Learning. All rights Reserved.

National Parkinson Foundation Awards $3.7 Million in Grants

To: NATIONAL EDITORS

Contact: Jamie Schwartzberg of National Parkinson Foundation, +1- 305-243-8165, [email protected]

MIAMI, Aug. 5 /PRNewswire-USNewswire/ — The National Parkinson Foundation (NPF) announced it will fund $3.7 million in grant programs dedicated to Parkinsons disease research, care and outreach worldwide. Grants were awarded to institutions in the Foundations network of 44 centers of excellence, 10 comprehensive care centers, and 10 outreach centers. Through centers alone, NPF reaches more than 50,000 patients with Parkinsons disease and almost 70,000 patients with movement disorders.

This year we received novel projects from a record number of centers and investigators worldwide, said Michael S. Okun, MD, National Medical Director of NPF. The NPF funding continues to catalyze important discoveries and advances that make a difference for patients and families suffering today with this disease. As a result, dollars donated to NPF have an immediate and measurable impact.

Centers Grants

NPF dedicated approximately $1 million (24 percent) to research, more than $640,000 (19 percent) to comprehensive care, and more than $1.5 million (57 percent) to outreach for the 2008-2009 fiscal year.

Research funded is largely clinical and included studies of genetics, potential treatment, cognition and depression, and fall prevention. Programs funded in comprehensive care were diverse and included grants focusing on advanced-stage Parkinsons disease and continuity of care. Of the 36 outreach grants, 28 sought to reach underserved and culturally diverse populations.

This program was supported, in part, by generous grants from the Parkinsons Unity Walk and The Parkinson Alliance.

Small Research Grants

NPF awarded seven grants totaling $350,000 for studies piloting novel research ideas.

Researchers who received grants include:

— Stephen Traynelis, PhD, Emory University;

— Eugene Mosharov, PhD,Columbia University;

— Esti Yeger-Lotem, PhD, Whitehead Institute for Biomedical Research, MIT;

— Yvonne Schmitz,PhD, Columbia University;

— Christophe Lo Bianco,PhD, Wallenburg Neuroscience Center at Lund University;

— Andrea Giuffrida, PhD, University of Texas Health Science Center; and

— Claudio Hetz, PhD, University of Chile.

About The National Parkinson Foundation

Founded in 1957 and headquartered in Miami, the National Parkinson Foundation is the oldest Parkinsons organization, with the most extensive grassroots network of centers, chapters and support groups in the U.S., Canada, and internationally. Since 1984, NPF has invested over $130 million in disease-related programs and is committed to increasing the quality of care for Parkinsons patients through research, education, care support and outreach services. For more information about NPF and allocation of grants please visitwww.parkinson.orgor call800-327-4545.

CONTACT: Jamie Schwartzberg of National Parkinson Foundation,

+1-305-243-8165, [email protected]

SOURCE National Parkinson Foundation

(c) 2008 U.S. Newswire. Provided by ProQuest Information and Learning. All rights Reserved.

TriMix Laboratories Announces New Partnership With American Pharmacy Solutions

CHERRY HILL, N.J., Aug. 5 /PRNewswire/ — TriMix Laboratories LLC today announced it has entered into an agreement with American Pharmacy Solutions as the exclusive pharmacy for prescription fulfillment of TriMix gel(TM). TriMix gel(TM) has been prescribed by doctors as a first line and secondary treatment for erectile dysfunction (ED). American Pharmacy Solutions (APS) is a licensed compounding pharmacy which makes TriMix gel(TM) medicine for each individual patient in response to a prescription from a physician. For more information on TriMix gel(TM), visit http://www.trimixgel.com/ .

APS Owner and President Steve Berklow states, “Our 50 years of experience in the pharmacy industry leaves us uniquely qualified to enter into this relationship with TriMix Laboratories. We look forward to delivering top shelf quality service and medicine to our patients.”

T.J. Harkins, President of TriMix Laboratories commented, “We are happy to have APS on board with us. They are a first class operation and they will undoubtedly make a positive reflection on us and become an important part of our patients’ health care regimen with TriMix gel(TM) and the other quality products they provide.”

TriMix gel(TM) is a gel-based treatment which has been prescribed for ED patients who have failed on Viagra(R), Levitra(R) and Cialis(R) type tablets or who could not tolerate the side effects. It uses an all-in-one ED gel(TM) Application System (pat. pend.) which stores, mixes and applies the medicine at time of use. One feature of this methodology of medicine delivery is that the medicine in this form does not have to be refrigerated and can be carried by the patient at room temperature. Additionally, TriMix gel(TM) uses FDA approved vasodilation components but does not have to be self injected with a needle because it is classified as a topical gel.

TriMix gel contains active ingredients which are classified as medicine and are listed in the US Pharmacopeia. Therefore, a patient would need a prescription from his physician to obtain TriMix gel. For an order form for your doctor, visit http://www.trimixgel.com/ and click the prescription form. Give the form to your doctor. He can fax a prescription to American Pharmacy Solutions at 877-387-4649 and the pharmacy will ship the medicine directly to the patient.

Recently, clinical trials were performed on TriMix gel(TM). All the test patients were men who had failed on Viagra(R), Levitra(R) or Cialis(R). These patients were given TriMix gel(TM). All the test patients received some degree of positive effect from TriMix gel(TM). It was determined that 40% of the test patients achieved a result sufficient for sexual intercourse over Viagra(R), Levitra(R) or Cialis(R) tablets. For more information visit the web at http://trimixgel.com/studies.html .

The profession of pharmacy has always been based on the patient-physician-pharmacist relationship, known as the “Triad.” Through this “Triad” relationship, patient needs are determined by a physician, who chooses a treatment regimen that may include a compounded medication. Physicians often prescribe compounded medications for various reasons, such as when a patient cannot ingest a medication in its available form. A pharmacist can prepare the medication in cream, liquid, gel or any other form that the patient can more easily take.

TriMix Laboratories LLC is a medical research and marketing firm specializing in the urological subspecialty of erectile dysfunction. American Pharmacy Solutions is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient. American Pharmacy maintains federal and state licenses and permits and is registered to dispense in almost all states. For more information, visit http://www.trimix-gel.com/ .

This press release contains forward-looking statements. These statements involve risks and uncertainties which may cause results to differ materially from those set forth in the statements. No forward-looking statement can be guaranteed and actual results may differ materially. Ingredients in TriMix gel(TM) are FDA approved but TriMix gel(TM) is a custom compound made in a pharmacy and therefore has not been approved by the FDA for treatment of ED. TriMix gel(TM) requires a valid prescription from a physician. You should discuss the risks and side effects associated with this drug with your physician. Before taking any action, consult your physician.

   Contact:   T.J. Harkins   TriMix Laboratories   Cherry Hill, NJ   856-428-7008  

TriMix Laboratories LLC

CONTACT: T.J. Harkins of TriMix Laboratories LLC, +1-856-428-7008

Web site: http://www.trimixgel.com/http://www.trimix-gel.com/http://trimixgel.com/studies.html

Aetna’s Strategic Resource Company Enters Into Agreement With The Boon Group(R)

Strategic Resource Company (SRC), an Aetna company (NYSE:AET), announced today that it has entered into an agreement with The Boon Group(R) to provide specialized products to government contractors, as well as direct billing and hour banking capabilities for all customers. The Boon Group(R) (Boon) is a leading third party administrator with more than twenty years of experience in providing non-traditional, full-service employee health products and services. By leveraging Boon’s unique product and service capabilities, SRC will further expand opportunities in the Commercial, Government and Labor markets.

“We have been evaluating this arrangement for over a year as part of our strategy to strengthen our number one position in the marketplace,” said John Webb, head of Government and Business Alliances. “Overall, we feel that combining our capabilities with those provided through The Boon Group(R) will provide maximum choice and satisfaction for our customers nationwide.”

SRC is one of the premier providers of limited benefits insurance plans, which can be valuable tools in helping employers, attract and retain talented employees. SRC’s product portfolio includes medical, dental, in-hospital cash, short term disability (STD), term life and vision options extended on a group basis to employees who are typically ineligible for company sponsored benefits. These employees are often paid an hourly wage, work on a part-time basis or participate during a waiting period for other employer-sponsored coverage. They also account for a sizable portion of the uninsured population in the U.S.

Through the agreement with The Boon Group(R), SRC will now be able to offer:

— Products for Government Contractors tied to the Service Contract Act, Davis-Bacon Act, or similar state prevailing wage and local living wage laws

— Direct Billing

— “Hour Banking” capabilities for the Labor markets, where some employees have a predetermined hourly amount contributed to their health plan by their employer based on the number of hours they work each month.

“We are excited about the new market opportunities that our relationship with The Boon Group(R) provides,” said Mark Schmidt, President of SRC. “We look forward to continuing to provide employers with affordable health care options for their employees and addressing the needs of the uninsured.”

About Aetna

Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 37.3 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. www.aetna.com

Better Nutrition Magazine Launches Healthy Living Guides

EL SEGUNDO, Calif., Aug. 5 /PRNewswire/ — Better Nutrition magazine today announced the launch of Better Nutrition Books. Beginning with the Better Nutrition Healthy Living Guides, a series of 32-page booklets, Better Nutrition Books will offer readers in-depth information on a variety of topics to help readers achieve optimal health at every stage of life.

The Healthy Living Guides, which will debut in health food stores this fall, include information on coenzyme Q10, hormones, immunity, inflammation, cleanse, probotics, skin care and water.

“Our readers are committed to optimal health and have asked us for more in-depth information than we can provide in a magazine article,” says Joanna Shirk, publisher of Better Nutrition. “The Healthy Living Guides are a natural brand extension for the magazine, and will give our readers the information they want in the form they have requested.”

Karolyn A. Gazella has been named managing editor of Better Nutrition Books. Gazella is the co-author of the Definitive Guide to Cancer (Celestial Arts 2007) and Return to Beautiful Skin (Basic Health 2008). She has written hundreds of articles on the topic of natural health and is the founding publisher of the Journal Integrative Medicine: A Clinician’s Journal.

“With more than 16 years experience as a writer and publisher, Karolyn has an impressive background in natural health education,” says Shirk. “She is the ideal person to help us launch this informative and comprehensive book division.”

Each booklet will retail for $4.95. Eight more booklets are planned for launch in early 2009 as well as more full length-books in the future.

About Better Nutrition: Since 1938, Better Nutrition’s mission is to responsibly inform health-food-store shoppers about the latest breakthroughs in nutritional approaches to optimal health and ongoing research into vitamins, botanicals (herbs), minerals and other supplements. Better Nutrition provides the link between consumers, independent health-food store, and the products carefully formulated by natural-product companies.

Better Nutrition endorses high-quality research and sensible nutrition. The magazine does not endorse any supplements. Better Nutrition is published by Active Interest Media (http://www.aimmedia.com/), in El Segundo, CA.

For retail information contact: Lisa Kurdziolek [email protected],

812-275-5510

Better Nutrition

CONTACT: Dayna Macy of Active Interest Media, +1-415-591-0729,[email protected], for Better Nutrition

Web site: http://www.aimmedia.com/

Shelter Offers Mental Health Services

By Janet Conner-Knox, The Wilson Daily Times, N.C.

Aug. 5–Wesley Shelter has expanded its services to include outpatient mental health therapy.

The name of the new clinic is Wesley Family Counseling Center, located at 106 E. Vance St.

Janet Hesmer, executive director, said a mental health clinic is a natural progression for the Wesley Shelter.

“We provide those services already to battered women and their children with the trauma that they have faced, she said. “But now we have opened our doors to the general public, except for abusers. Mental Health therapy was a need in our community that we could not ignore.”

The counseling center does not give services to abusers for the protection of abused people who are being helped there, but they do see male patients.

Wesley Family Counseling Center has been open since January, and Pat Peykar, therapist for the shelter, said it’s been very busy.

Peykar said that since mental health reform and the closing of Wilson-Greene Mental Health Center, there was no backup mental health services for Wesley Shelter.

Shelter staff workers cooperate closely with the Department of Social Services, Wilson Police Department, the Wilson County Sheriff’s Office and the Wilson County Health Department.

Peykar said all of the agencies were asking the same question: “Where do we refer people who need mental health services?”

So Peykar said the staff at Wesley Shelter decided it ought to offer mental health services.

But Peykar said a person does not have to be in need of shelter to come there for mental health services because the shelter is providing outpatient services, too.

“People are coming in who are suffering through these harsh economic times,” said Peykar. “We see people who are suffering with depression, and we are starting to see a lot of war veterans from Iraq.”

She also said a lot of parental counseling is done there at the center.

“There is no manual for a parent to tell them the dos and don’ts of good parenting — parenting is a tough job,” Peykar said. “And lots of times parents need help and support as they try to parent.”

The center also provides substance abuse services and works with adolescents, children and couples.

Peykar said an awful lot of people come in to see her through their employee assistance program for work-related stress.

“There are a lot of people that work 60-hour work weeks and don’t have time for their families,” she said. “Sometimes it (therapy) is very short term and solution focused. We’re not always dealing with people who need to be hospitalized and are severely mentally ill.”

A number of families left behind after a family member has been deployed to Iraq suffer from stress and need counseling. Wesley Family Center is starting a support group called Homeland Heros. Peykar said there are a number of Homeland Hero groups in other parts of the state and country.

Peykar said she hopes people will understand that anyone might need mental health help at some time in their lives and wishes there was not the term “mental health” but that everyone thought of it as just health.

She said there is no separation of the mind and body — anxiety and depression affect the whole body.

“If you have high blood pressure or depression, they are both treatable, and it’s all health,” said Peykar. “The only people that divorce the brain from the body are insurance companies.”

All income levels are accepted at the center. There is a sliding fee for people without insurance. Insurance plans are also taken at the center, including Tri-care, which is the military health insurance, and Medicaid.

The new medical center has plans to grow.

There is a therapeutic playroom already set up for children, but soon there will be a child therapist also, and an observation window will be put in the playroom.

There are plans to hire a family therapist.

Also coming soon will be a support group for parents called Parents Anonymous, where parents will get to share parenting information.

The Mental Health Association of Wilson will be moving its offices to Wesley Shelter in the fall.

“We don’t want the people of Wilson to suffer,” said Hesmer.

“We want them to be healthy.”

[email protected] — 265-7847

============================================================

FOR MORE INFORMATION:

Contact Wesley Family Counseling Center for services they provide: call 252-291-2344

Web site: www.wesleyshelter.org

—–

To see more of The Wilson Daily Times or to subscribe to the newspaper, go to http://www.wilsondaily.com/.

Copyright (c) 2008, The Wilson Daily Times, N.C.

Distributed by McClatchy-Tribune Information Services.

For reprints, email [email protected], call 800-374-7985 or 847-635-6550, send a fax to 847-635-6968, or write to The Permissions Group Inc., 1247 Milwaukee Ave., Suite 303, Glenview, IL 60025, USA.

Vitamin C Injections Help Reduce Tumors

Researchers claim that a high dose injection of vitamin C was able to cut brain, ovarian and pancreatic tumors in half among laboratory mice involved in a recent study.

Conversely, Cancer Research UK argues that other studies have shown that these large doses may actually interfere with cancer treatment.

The team at the National Institutes of Health in Maryland suggested that the vitamin, also called ascorbate, could kill cancer cells in the laboratory.

The successful trials with laboratory mice is causing some researchers to believe that the treatment could be used in humans at similar levels ““ up to four grams per kilo of bodyweight.

The mice involved were bred to have malfunctioning immune systems. They were injected with human cancer cells, and the vitamin was injected into their abdominal cavity.

Tumor growth and weight fell by between 41% and 53%, and while in untreated mice, the disease spread rapidly to involve other body parts, no such spread was seen in the vitamin C-treated animals.

The researchers wrote: “These pre-clinical data provide the first firm basis for advancing pharmacologic ascorbate in cancer treatment in humans.”

The treatment works because vitamin C reacts with this chemical make-up, producing enough hydrogen peroxide to kill the cell, while leaving healthy cells unscathed.

“This is encouraging work but it’s at a very early stage because it involves cells grown in the lab and mice,” said Dr Alison Ross, from Cancer Research UK.

“There is currently no evidence from clinical trials in humans that injecting or consuming vitamin C is an effective way to treat cancer.”

“Some research even suggests that high doses of antioxidants can make cancer treatment less effective, reducing the benefits of radiotherapy and chemotherapy.”

On the Net:

ICW LifeSensor Passes Performance Benchmark

WALLDORF, Germany, Aug. 5 /PRNewswire/ — 10,000 virtual users access 10 million LifeSensor(R) personal health records simultaneously. Response times are stable at less than two seconds. In a nutshell, this is the result of a ten-day performance test conducted by eHealth specialist InterComponentWare AG (ICW) at the Hewlett Packard European Performance and Benchmark Center. The result proves again: LifeSensor is ready for large-scale use.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071126/NEM090LOGO )

The performance test verified LifeSensor’s capacity, performance and scalability under extreme conditions. LifeSensor is a Web-based personal health record that enables anyone to safely store copies of their health relevant information and manage it, no matter when or where. Only the owner has access to this personal information. However, users can permit their doctor, pharmacist, hospital or other health care providers to access their data.

The performance test scenario not only simulated access by 10,000 virtual users to a database consisting of 10 million personal health records, but also simulated use by 20,000 doctors and pharmacists. While patients, for example, enter health information relating to their most recent medical appointments or create new appointments, doctors process larger amounts of data when synchronizing their patients’ personal health records with their own local patient documentation systems. Peak loads during the performance benchmark showed that up to 700 simultaneous record accesses were possible, with system performance remaining stable. That means that even over a prolonged period of time up to 8,500 users could process personal health records at any given time. At times of peak use, more than 10,000 simultaneous users were online. The results confirmed that the LifeSensor personal health record is not only highly capable and scalable but also especially secure.

“ICW has done exemplary work in designing and developing the LifeSensor personal health record platform. Running on HP’s hardware, LifeSensor delivers outstanding results and fulfills the requirements of markets worldwide,” says Hans-Jurgen Preuss, sales manager for the health sector of Hewlett Packard Germany.

“Personal health record platforms need to be scalable, highly accessible, stable, and above all secure, so that users and health care providers can use the records anytime, world-wide. The test results prove once again that LifeSensor is ready for widespread use,” adds Peter Reuschel, CEO of ICW.

Test parameters

The benchmark test was conducted using industry-standard hardware and operating system software from leading technology providers. Among the equipment used was ProLiant DL 380 G5 servers with quad-core Intel-Xeon processors and AMD Opteron quad-core processors. Also used was an HP EVA 4000 SAN storage system equipped with 5 TB hard disk storage. The system was run using the Novell Suse SLES 10 64-bit operating system, and with Oracle 10g R2 and Real Application Cluster Option as the database. The desired high level of user load was simulated using Apache JMeter freeware.

Along with ICW’s Master Patient Index (MPI), one of the components of ICW’s Professional Exchange Server, LifeSensor is the second solution out of the ICW portfolio to be subjected to performance testing at the Hewlett Packard European Performance and Benchmark Center. Together with its partners, ICW conducts periodic performance benchmarks for the continuous improvement of its product line.

   For additional information, please contact:   InterComponentWare AG (ICW)   Dirk Schuhmann   Tel: +49 (0)6227-385-133   Fax: +49 (0)6227-385-199   E-Mail: [email protected]    About InterComponentWare:  

InterComponentWare AG (ICW) is a leading international eHealth specialist with locations in Germany, the United States, Austria, Switzerland, and Bulgaria. Its solutions for networking the various players in the healthcare system lastingly improve process-oriented communication and data integrity, and therefore also the quality of healthcare. Among other things, ICW develops and distributes software and hardware components for national and regional eHealth infrastructures, the LifeSensor personal health record as well as networking solutions for hospitals and physician offices. As part of the bIT4health consortium, ICW provided important consulting services for the implementation of the electronic health card in Germany, is involved in the Austrian eCard project and has recently won the pilot project for the national health card in Bulgaria.

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20071126/NEM090LOGOAP Archive: http://photoarchive.ap.org/PRN Photo Desk, [email protected]

InterComponentWare AG

CONTACT: Dirk Schuhmann of InterComponentWare AG, +49-0-6227-385-133, orFax, +49-0-6227-385-199, [email protected]

Web site: http://www.icw-global.com/

The Revision Decision; Unrealistic Expectations of Cosmetic Surgery Patients and Doctors Can Lead to Revision Surgeries

CHICAGO, Aug. 5 /PRNewswire-USNewswire/ — The American Academy of Cosmetic Surgery urges patients to follow certain precautions to avoid what is now being termed “revision cosmetic surgery.” Revision cosmetic surgery occurs when the patient is unhappy with the results of the procedure and undergoes another surgery to fix it. In such cases, the patient may return to the same doctor to achieve better results or choose to visit another due to lack of confidence in the previous doctor.

All too often, patients desire unrealistic results from cosmetic procedures. To combat this there needs to be an honest conversation between the doctor and patient prior to the surgery in order to prevent a disgruntled patient and undesirable results.

“Patients wishing for revision or secondary surgeries can be most challenging to a cosmetic surgeon because often times these patients are dissatisfied, angry and doubtful,” says AACS President, Steven Hopping, M.D., of Washington D.C. “What happened the first time in most cases is that the patient and doctor did not clearly express their expectations prior to the surgery. The doctor doing the revision surgery has to make sure that same mistake doesn’t happen the second time around.”

“The patient must also keep in mind that some results are completely unattainable. Especially those who seek cosmetic surgery as a quick fix to alter their appearance or want to have multiple procedures done at once need to be educated on the risks. On the other hand, doctors have to push ego aside and realize that he or she may not be able to ‘fix’ everything and relay that honestly to the patient,” said Dr. Hopping.

The AACS reminds patients to seek the following information when considering surgery for the first or second time.

   -- Ask for the surgeon's experience    -- Ask for referrals from friends    -- Ask for before-and-after photographs    -- Ask where your surgery will be performed   

To learn more information about choosing a cosmetic surgeon and to search for cosmetic surgeons in your area, visit the Academy’s patient education site: http://www.cosmeticsurgery.org/. Additionally, doctors and patients are available to speak on this subject.

The American Academy of Cosmetic Surgery is a professional medical society whose members are dedicated to patient safety and physician education in cosmetic surgery. Most members of the AACS are dermatologic surgeons, facial plastic surgeons, head and neck surgeons, general surgeons, oral and maxillofacial surgeons, plastic surgeons or ocular plastic surgeons – all of whom specialize in cosmetic surgery. AACS is an organization that represents all cosmetic surgeons in the American Medical Association through its seat in the AMA House of Delegates.

American Academy of Cosmetic Surgery

CONTACT: Sarah Massier of the American Academy of Cosmetic Surgery,+1-312-981-6763, [email protected]

Web Site: http://www.cosmeticsurgery.org/

Kowa Acquires ProEthic Pharmaceuticals

Kowa Company, a privately-held company headquartered in Nagoya, Japan, has acquired ProEthic Pharmaceuticals, a specialty pharmaceutical company based in Montgomery, Alabama.

Effective September 1, 2008, ProEthic will change name to Kowa Pharmaceuticals America and will assume responsibility for all sales and marketing functions currently operating in Montgomery, Alabama. ProEthic’s clinical development group will transfer to Kowa Research Institute, which is located in Morrisville, North Carolina.

The first pharmaceutical product to be launched by the new company will be pitavastatin, a novel HMG CoA reductase inhibitor for the treatment of hyperlipidemia. Pitavastatin is sold in Japan, Korea and Thailand under the brand Livalo. Pitavastatin has recently completed Phase III clinical development in Europe and the US.

Yoshihiro Miwa, president and CEO of Kowa, said: “The opportunity to enter the US pharmaceutical market represents a significant step towards Kowa’s vision of creating a global pharmaceutical organization. Pharmaceuticals represent one of Kowa’s fastest growing businesses, and we are happy that Kowa Pharmaceuticals America will now be part of that plan.”

Fred Williams, Quest Diagnostics, Joins The Center for Health Value Innovation Board of Directors

The Center for Health Value Innovation (www.vbhealth.org), the nation’s premier organization dedicated to establishing value and producing evidence for sustainable health and financial improvement, has appointed Fred Williams, director of health benefits management at Quest Diagnostics Incorporated, to its board of directors. Quest Diagnostics, the nation’s leading provider of diagnostic testing, information, and services and a member organization of the Center, was recently awarded the National Business Group on Health (NBGH) 2008 Best Employers for Healthy Lifestyles Gold Award for its HealthyQuest employee wellness program.

According to Cyndy Nayer, founder and executive director of the Center, “Fred Williams and Quest Diagnostics make brilliant additions to our organization at a time when we are seeing a burgeoning demand for the Center’s analytic tools and educational programs. More and more, it’s become not just about taming the healthcare cost trend but about investing in people’s lives.”

Williams, a 30-year veteran in employee benefits management, commented on the appointment, “Quest Diagnostics and the Center share a mission to innovate, implement, and measure the success of lifestyle improvement programs designed to encourage healthier lifestyles for employees. I am honored to serve in a leadership role and look forward to working with the Center and its members to help accelerate the introduction and adoption of employee wellness best practices.”

He added, “Value-based health design helps employers like us to expand upon our efforts to educate individuals about their personal health risk factors. When we help people to understand their daily behaviors, they are better equipped to adopt new behaviors for better health. It’s about making a real difference in our employees’ lives by making their choices simpler and more intuitive.”

Quest Diagnostics’ HealthyQuest initiative provides employees and their spouses or domestic partners with the information they need to make healthcare and lifestyle choices leading to better health. The program is based largely on the company’s Blueprint for Wellness(TM) risk assessment product, which combines behavior and lifestyle choices with diagnostic test results to produce a personalized report identifying health risks and opportunities for improvement. Between 2005 and 2007, Quest Diagnostics’ HealthyQuest program helped its participants to substantially lower their health risks by adopting more healthful behaviors, such as quitting smoking and exercising more frequently. Today, more than 70 percent of participants have achieved an assessment rating that indicates a low risk of developing major health problems, compared to 60 percent when the program began.

Williams explained, “Like the Center, we have been looking at healthcare in new ways and taking what we’ve learned directly to our employees. It has made an enormous difference in helping employees make important lifestyle changes, anticipating major medical problems, like diabetes, becoming more compliant with colorectal cancer screening, and helping change harmful behaviors, such as smoking.”

Member inquiries: www.vbhealth.org or [email protected].

About The Center for Health Value Innovation

Launched in 2007, The Center for Health Value Innovation is a not-for-profit (501c3) organization representing industry stakeholders committed to sharing the evidence that value-based health designs improve health status and reduce health cost inflation. Visit www.vbhealth.org.

About Quest Diagnostics

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: www.questdiagnostics.com.

Take Care Clinics Open at Three Walgreens in Wichita

Take Care Health Systems, one of the largest managers of convenient care clinics and a wholly-owned subsidiary of Walgreens (NYSE, NASDAQ: WAG), has opened three Take Care Clinics at Walgreens drugstores in Wichita. The clinics are walk-in, professional health care centers open seven days a week with extended evening and weekend hours. Take Care Health Systems now has 15 clinics in the region, including 12 in the Kansas City metro area. Additional expansion is planned for the state this year, including three additional sites in Wichita, expansion in Kansas City and a new market launch in Topeka.

“Take Care Clinics bring a high-quality, affordable and convenient healthcare option to the communities where we operate,” said Peter Miller, Take Care Health Systems’ President and CEO. “As one of our first and most established markets, Kansas City has shown incredible growth, driven by patient awareness and acceptance of our model. We look forward to serving even more Kansas residents with our launch in Wichita.”

Take Care Clinics in Wichita are staffed by board-certified family nurse practitioners who treat patients 18 months and older for common illnesses such as strep throat, ear and sinus infections, pink eye and poison ivy, and are licensed to write prescriptions that can be filled at the patient’s pharmacy of choice. Take Care Nurse Practitioners also provide school, sports and camp physicals and offer vaccinations for flu, hepatitis B, meningitis and tetanus.

Clinics have two patient examination rooms, exam tables, sinks, innovative patient registration kiosks and electronic medical record technology for visit documentation. Clinics are open Monday-Friday, 8 a.m. – 7:30 p.m.; Saturday and Sunday, 9:30 a.m. – 5 p.m., and are located at the following Walgreens drugstores in Wichita:

 -- Wichita - 710 N. West Street     -- Wichita - 5505 E. Harry Street -- Wichita - 9525 E. 21st Street N. 

Three additional clinics are planned to open by the end of the year at the following Walgreens drugstores:

 -- Wichita - 555 N. Maize Road      -- Wichita - 333 W. 13th Street N. -- Wichita - 3770 N. Woodlawn Street 

Take Care Health Systems has partnered with numerous insurers including Aetna, CIGNA, Coventry, Humana, Multiplan/PHCS, UnitedHealthcare, and traditional Medicare and Medicaid. If insured by one of these plans, patients pay their regular co-pay or coinsurance amount. For the uninsured or cash payers, prices average $59-$74 and are listed on clinic sign-in kiosks.

“Since our first clinic opened in November 2005, Take Care Nurse Practitioners have treated nearly 600,000 patients nationwide,” said Nancy Zaner, Regional Nurse Practitioner for Take Care Health’s West/Southwest Region, including the Kansas markets. “Take Care Nurse Practitioners integrate with the local medical community to coordinate care for patients and provide an excellent healthcare experience.”

Take Care Nurse Practitioners encourage all patients to have a health care home, a provider they see routinely for on-going medical needs and routine exams. If a patient’s condition falls outside of the scope of service at the clinic, the patient is referred back to his/her primary care provider for follow-on care. If a patient does not have a primary care provider, nurse practitioners will offer a list of providers in the area accepting new patients. Take Care Nurse Practitioners collaborate with local physicians who are available for consultation at all times the nurse practitioner is treating a patient. Collaborating physicians and other local providers work with Take Care Nurse Practitioners to accept patient referrals.

Take Care Health Systems uses nationally recognized, evidence-based clinical guidelines for treatment and electronic medical record technology allowing patients to take visit records to other providers, promoting continuity of care. Take Care Nurse Practitioners follow quality and safety standards as outlined by the Convenient Care Association, the industry’s trade association.

Take Care Health Systems is part of Walgreens new Health and Wellness division, alongside Walgreens recently acquired I-trax/CHD Meridian Healthcare and Whole Health Management, providers of worksite health centers that operate under the name Take Care Employer Solutions. Including Take Care Clinics, the Walgreens Health and Wellness division manages approximately 550 worksite health and wellness centers and retail health clinics.

Take Care Health Systems currently manages 197 clinics in 24 markets throughout 14 states, including Atlanta, Chicago, Cincinnati, Cleveland, Columbus, Denver, Green Bay, Wis., Houston, Kansas City, Las Vegas, Madison, Wis., Miami, Milwaukee, Nashville, Tenn., Orlando, Fla., Oshkosh, Wis., Peoria, Ill., Pittsburgh, Rockford, Ill., St. Louis, Tampa, Fla., Tucson, Ariz., West Palm Beach, Fla. and Wichita, Kan.

About Take Care Health Systems(SM)

Take Care Health Systems (www.takecarehealth.com), a wholly-owned subsidiary of Walgreens, is part of Walgreens Health and Wellness division, which includes Take Care Consumer Solutions, managers of convenient care clinics located at Walgreens drugstores nationwide, and Take Care Employer Solutions, managers of worksite-based health and wellness services. The company combines best practices in health care and the expertise and personal care of providers to deliver access to high-quality, affordable and convenient health care to all individuals. The Take Care Consumer Solutions group currently manages 197 Take Care Clinics in 24 markets throughout 14 states, with plans to have approximately 400 clinics in operation by the end of 2008. Patient care at each of the Take Care Clinics is provided by Take Care Health Services, an independently owned state professional corporation established in each market. Take Care Employer Solutions manages primary care, health and wellness and occupational health centers at 355 employer campuses across more than 170 clients in 44 states, including the District of Columbia and Guam, with approximately 400 sites projected by the end of 2008.

About Walgreens

Walgreens (www.walgreens.com) is the nation’s largest drugstore chain with fiscal 2007 sales of $53.8 billion. The company operates 6,356 drugstores in 49 states, the District of Columbia and Puerto Rico. Walgreens provides the most convenient access to consumer goods and cost-effective health care services in America through its retail drugstores, Walgreens Health Services division and Walgreens Health and Wellness division. Walgreens Health Services assists pharmacy patients and prescription drug and medical plans through Walgreens Health Initiatives Inc. (a pharmacy benefit manager), Walgreens Mail Service Inc., Walgreens Home Care Inc., Walgreens Specialty Pharmacy LLC and SeniorMed LLC (a pharmacy provider to long-term care facilities). Walgreens Health and Wellness division includes Take Care Health Systems, which is comprised of: Take Care Consumer Solutions, managers of 197 convenient care clinics at Walgreens drugstores, and Take Care Employer Solutions, managers of worksite-based health and wellness services at 355 employer campuses.